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  Periodontal diseases are bacterially induced, inflammatory diseases which are 
responsible for loss of alveolar bone and connective tissue supporting the teeth which results in 
loss of teeth. Gram negative anaerobic bacteria are highly associated with these diseases. One of 
them is Porphyromonas gingivalis belonging to the phylum Bacteroidetes. Infection by P. 
gingivalis is recurrent after physical removal of the bacteria from the oral cavity and even after 
antibiotic treatment as development of resistance is not rare. Hence complete understanding the 
biology of this bacterium is of significance.  
 This gram negative obligate anaerobe, being aerotolerant, manages to survive inside the 
oral cavity, where oxidative stress is ubiquitous. Genome sequence of P. gingivalis shows the 
presence of a transcriptional regulator OxyR which is a homologue of OxyR present in E. coli. P. 
gingivalis OxyR induces the expression of antioxidant defense genes like sod, ahpC-F, dps to 
 xiii 
protect the bacteria from oxidative stress.  Expression of P. gingivalis OxyR regulon is not very 
well understood. 
 Microarray studies carried out in our lab using P. gingivalis W83 to study gene regulation 
by OxyR, indicated that several genes in P. gingivalis are co-regulated by iron-and OxyR. 
Literature also supports that in iron deplete conditions genes involved in oxidative stress are 
down-regulated. These studies formed the basis of our hypothesis that OxyR might regulate the 
genes in P. gingivalis in an iron dependent manner.   
 To study the mechanism of regulation by P. gingivalis OxyR and to determine whether 
OxyR regulation is iron dependent, two approaches were applied - in vitro characterization of 
binding and in vivo characterization. 
 First step of in vitro characterization was to perform CHIP-chip assay to determine 
OxyR-binding sites present on the genomic DNA of P. gingivalis. As this assay was performed 
under completely anaerobic conditions, the target fragments to which OxyR was found to bind 
during this assay were not same as reported in literature. These and the fragments reported in 
literature were used for EMSA. EMSAs carried out using crude cell lysates and in vitro OxyR 
protein preparations showed expected results but the results were not reproducible.  In vivo 
expressed and purified P. gingivalis OxyR never bound to the target fragments used. Preparation 
of a stable protein preparation and improvement in the parameters of EMSA is very important to 
further investigate the binding in vitro.  
 The second approach is based on in vivo characterization of binding. This requires 
tagging the P. gingivalis OxyR at its C-terminus with fluorescent protein to observe its binding 
to the target DNA sequences. Fluorescently tagged OxyR, is expected to emit fluorescence from 
a highly localized area to produce sharp fluorescent spots when it is bound to its target sequences. 
 xiv 
Unbound OxyR is expected to emit a fluorescent signal which is spread over the entire area of 
the cell. This technique will help to determine the conditions under which OxyR binds to its 
target DNA sequences. This provides a means to confirm the results obtained from in vitro 
characterization instead of just extrapolating them. 
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1.1. Introduction  
 Drawing analogy to the human body, oral cavity has its own natural micro-flora1-3. All 
dental and mucosal surfaces are colonized by diverse pathogenic and non-pathogenic 
microorganisms4. The oral cavity comprising of the teeth, gingival sulcus, attached gingiva, 
tongue, cheek, lip, hard and soft palate have various distinct habitats of microorganisms5. The 
natural micro-flora has a specific composition that varies for different sites in the oral cavity due 
to differences in prevailing biological conditions4. Studies document the presence of 500 to 700 
common oral species and culture independent molecular methods have identified 600 different 
species or phenotypes4. Studies have identified the presence of specific bacterial strains 
representing mainly six bacterial phyla in the oral cavity namely, the Firmicutes (species of 
Gemella, Streptococcus, Eubacterium, Selenomonas and Veillonella), Actinobacteria (species of 
Actinomyces, Atopobium, Rothia), Proteobacteria (species of Neisseria, Eikenella, 
Campylobacter), Bacteroidetes (Species of Porphyromonas, Prevotella, Capnocytophaga), 
Fusobacteria (species of Fusobacterium, Leptotrichia) and the TM7 phylum. Some species like 
Gemella, Granulicatella, Streptococcus and Veillonella reside in most of the sites in the oral 
cavity while some strains are very site specific3. 
As mentioned earlier, this plethora of microorganisms encompass both essential and 
pathogenic organisms. Beneficial effects of some oral bacterial strains include contribution 
towards the maintenance of gastrointestinal and cardiovascular health via metabolism of dietary 
nitrate to nitrite by reduction6. Evidences indicate the existence of a cross-talk between some of 
resident bacteria and cells of the oral mucosa, which contribute towards down regulating the 
potentially damaging pro-inflammatory host responses to normal microflora7,8. Whereas, certain 
microorganisms residing the oral cavity are responsible for a number of infectious diseases, 
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involving caries (tooth decay), periodontitis (gum disease), endodontic infections (root canal), 
alveolar osteitis (dry socket) and tonsillitis. Studies have revealed that most of these infections 
are caused by a consortia of microorganisms5. It has also been observed that individuals 
experiencing a good oral health do not exhibit a complete absence of infectious organisms, hence 
presence or absence of a particular organism is not clear indication of the onset of disease. 
Diseases are initiated either due to change in the relative or absolute numbers of pathogenic and 
beneficial organisms or due to modulation of host factors which result in loss of harmony 
between the organism and the host9.   
1.1.1. Periodontitis. One of the most common oral diseases is periodontitis3. It has been 
estimated that at least 35% of dentate U.S adults aged 30 to 90 years suffer from periodontitis10. 
Periodontitis is a set of inflammatory disease affecting the periodontum that includes periodontal 
tissues surrounding and supporting the teeth. The periodontum is made up of four tissues, namely, 
the gingiva (gum tissue), cementum (outer tissues of the roots of teeth), alveolar bone (sockets 
where the teeth are anchored) and periodontal ligaments (connective tissues joining the 
cementum and the alveolar bone). Periodontitis is marked by the infection of periodontal 
ligament fibers and alveolar bone supporting the teeth, which ultimately leads to loosening and 
loss of teeth11. Poor oral hygiene leading to accumulation of mycoses and bacterial biofilms at 
the gum line account for the primary etiology of periodontitis12-14. Periodontitis lesions are 
usually accompanied with gingival redness and swelling. The onset of periodontitis may occur 
through gingival inflammations, however all gingivitis lesions do not lead to periodontitis15. 
Visual detection of gingival changes is suggestive of periodontitis but often misleading 
since periodontitis is not always accompanied by physiological changes in the gingiva. Early 
symptoms suggesting the onset of periodontitis involve bleeding on probing (BOP), pocket 
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probing depth (PPD), clinical attachment loss (CAL) and radiographically assessed alveolar bone 
loss16, among which PPD and CAL are the most common techniques. Apart from oral infections, 
periodontitis has been associated with an increased inflammation of the body observed by raised 
levels of C-reactive protein and Interleukin-6 (IL-6)17-19. This disease also leads to memory 
impairment20,21 for older patients and furthermore has been linked to an increase in susceptibility 
to myocardial infarction22, artherosclerosis23,24 and an increased risk of stroke22. Individuals with 
impaired fasting glucose (IFG) and diabetes mellitus have a higher degree of periodontal 
inflammation which leads to a constant elevated blood glucose level due to the constant systemic 
inflammation25,26. 
The etiology of periodontal diseases have been the subject of investigation for almost a 
century27-29. Two fundamental schools of thought are prevalent in the literature where, one 
proposed bacterial plaques as the cause of periodontitis whereas the other suggested bacterial 
colonization to be a secondary event30. Over the past few decades, studies have shown the role of 
dental plaque organisms in the etiology of periodontitis31, where a positive correlation was 
established between the severity of periodontal disease and the amount of dental plaque. Clinical 
studies on humans and experimental animals have demonstrated the presence of bacterial plaques 
prior to periodontal infection32-34. Furthermore, a microbial concentration dependant periodontal 
infection provided additional proof of the theory35. 
1.1.2. Causative Microbes and P. gingivalis. It has been observed that a wide range of microbes 
are responsible for initiation of periodontal diseases but generally more severe forms of the 
disease in adults are observed to be associated with the increased number of Gram negative 
anaerobic bacteria9. Statistical studies performed on healthy and diseased individuals are in 
compliance with this observation, pointing towards B. forsythus, P.gingivalis, T. denticola, and S. 
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noxia as potential periodontal pathogens10. Among the array of Gram negative bacteria, 
evidences for most pathogenicity has been observed for Porphyromonas gingivalis. 
P. ginigivalis, is a Gram negative, obligate anaerobic bacterium36. P. gingivalis is 
considered to be the causative agent in 37 to 63% of juvenile periodontitis, whereas it accounts 
for 40 to 100% of periodontitis occurring in adults. P. gingivalis forms a higher fraction of the 
oral microbiota in deep periodontal pockets37. This pathogen can adhere to the oral cavity like 
teeth, oral mucosa and other oral bacteria through its long, filamentous structures called 
fimbrae38. P. gingivalis is a late or secondary colonizer of oral cavity where it depends on 
antecedent organisms which create the necessary environment for colonization of P.gingivalis9. 
Studies have shown that highly virulent P. gingivalis strains cause severe tissue damage and 
even death, whereas less virulent ones have a milder effect on periodontal tissues. The presence 
of the organism at inaccessible areas of the oral cavity makes it difficult for eradication through 
mechanical techniques. Bacteria rapidly develop resistance to antibiotics. Infections are recurrent 
even after antibiotic treatment. Hence more targeted and longer-lasting approaches are needed to 
reduce colonization of P. gingivalis in the oral cavity. For that a complete understanding of the 
biology of P. gingivalis is necessary39. 
The predominant role played by P. gingivalis in adult periodontitis together with their 
virulent pathogenicity are the main reasons for designating them as prime pathogens for adult 
periodontitis. Virulence differs among various strains of P. gingivalis. Studies on the association 
of individual hetero-duplex types of P. gingivalis with periodontitis were analyzed and strain 
W83 was statistically found to be highly associated with the disease. While both healthy 
individuals as well as individuals with periodontitis harbor multiple strains, their distribution is 
different among these two groups of people. The virulent strains present in individuals with 
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periodontitis are likely to dominate the ecological niche and inhibit the colonization of less 
virulent strains38. Since P. gingivalis is an opportunistic pathogen, it is also true that virulence is 
not restricted to a particular clonal type9. To sum up, periodontal diseases range in severity, rate 
of progression of the disease, causative organisms involved, number of affected teeth and the 
susceptible age-group9. Our research group is working on P. gingivalis strain W83, which is 
fully sequenced and is believed to be the most virulent strain.   
1.1.3. LysR type transcriptional regulator (LTTR). LTTR is the largest known, highly 
conserved family of prokaryotic DNA binding proteins consisting of 800 members40. The 
members of this family are identified on the basis of their amino acid sequences41. The 
transcriptional activator LysR is a well studied and the best characterized member of this family. 
It activates the expression of a divergently transcribed lysA gene in E. coli, negatively regulating 
its own expression42. Since the discovery of lysA, many more LTTRs have been identified. 
Members of this group belong to extremely diverse groups of bacteria and regulate genes with 
diverse functions like metabolism, cell division, quorum sensing, virulence, motility, nitrogen 
fixation, oxidative stress responses, toxin production, attachment and secretion40,41. In spite of 
this diversity, important structural regions remain highly conserved among the family members. 
LTTRs are made up of approximately 330 amino acids having helix-turn-helix (HTH) motif at 
the N-terminus for DNA binding site among which residues 20 to 80 are the most highly 
conserved. The C terminus of these proteins is composed of α/β subdomains connected through a 
hinge/cleft40 which is believed to accommodate a co-inducer43. The C terminus has a co-factor 
binding domain which helps the proteins to interact with DNA at their major groove. 
Comparatively less conservation at the amino acid level is observed at the C terminus of LTTRs.  
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 Studies have shown that LTTRs exhibit negative auto-regulation. Initially these proteins 
were believed to be the transcriptional activators of a single, divergently transcribed gene, 
though some of them showed repressor like effects for some promoters41. Over the years, 
research work has proved that LTTRs can behave as either activators or repressors of operonic 
genes. Although these proteins mostly regulate transcription of divergently transcribed genes, 
those located elsewhere on the bacterial chromosome could also be regulated44,45. LTTRs protect 
unusually long regions of DNA from DNase1 digestion suggesting that these are multimeric 
nature of these proteins.  
1.1.4. Reactive oxygen species (ROS). These moieties are generated during a number of cellular 
processes some of which include incomplete reduction of oxygen during respiration, radiation 
exposure and release from macrophages in response to microbial invasion46. It has been observed 
that cellular redox homeostasis is dependent on the concentration of intracellular ROS47. ROS 
can have damaging effects on intracellular DNA, proteins, lipids membranes and are responsible 
for initiation of many degenerative processes like DNA damage and mutations47,48. Generally, 
cells respond to increased levels of ROS through proteins whose activities are regulated by 
oxidation and one such representative protein that has been well documented in the literature is 
OxyR47,48. OxyR protein present in a facultative anaerobic bacteria, Escherichia coli, has been 
well studied over the past few decades48. 
1.1.5. E. coli OxyR. OxyR in E. coli is a transcriptional regulator belonging to the LTTR 
family48. This 34 KDa protein49 acts as a transcriptional inducer for genes involved in bacterial 
defense against oxidative stress47,48. In response to increased concentration of intracellular 
hydrogen peroxide, OxyR rapidly activates the transcription of OxyS (a small, non-translated 
regulatory RNA), katG (hydrogen peroxidase I), gorA (glutathione reductase), grxA 
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(glutaredoxin A) ,  ahpC (alkyl hydroperoxidase C) and dps (non-specific DNA binding 
protein)48,50. It has been observed from prior studies that OxyR can negatively regulate its own 
expression49. To investigate the mechanism of OxyR regulation, studies were carried out to 
determine whether this increase in transcription of target genes was due to increased levels of 
OxyR protein within the bacterial cell. Neither the total amount of OxyR nor its synthesis 
increased significantly after peroxide treatment, suggesting that a modification in the pre-existing 
OxyR is responsible for elevated expression of the oxyR regulon. Further studies proved that the 
capacity of OxyR to activate transcription is directly dependent on its redox state, the oxidized 
form being the only transcriptionally active form48.  
 The intracellular environment in prokaryotic and eukaryotic cells is reducing in nature. 
Studies have shown the redox potential of E. coli cytosol to be approximately -0.26 to -0.28 
volts47,51. Hence protein disulphide bonds do not occur frequently47,51. Hence, under normal 
circumstances intracellular OxyR exists in its reduced (inactive) form. Only when the 
intracellular redox homeostasis gets disrupted due to increased concentration of hydrogen 
peroxide, OxyR gets converted into oxidized (active) form48. The two forms, oxidized (active 
form) and reduced (inactive form), are readily and rapidly interconvertible48. 
 Oxidized as well as reduced OxyR binds to the promoters of its target genes with high 
affinity suggesting that the reason for transcriptional activation by only the oxidized form is not 
due to greater affinity for DNA binding by oxidized form. In fact, it is postulated that low 
concentrations of reduced form of OxyR bound to oxyR promoters are always present intra-
cellularly. A conformational change due to oxidation in the OxyR that is already bound to its 
promoters is responsible for activation. This hypothesis is further established by the difference in 
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the lengths of the OxyR footprint under oxidizing and reducing conditions, elucidated in the 
subsequent sections48.  
 Being a member of the LysR family, OxyR possesses a HTH domain at its N-terminus 
which was proposed to be directly involved in DNA binding and a C-terminal regulatory domain. 
Random mutagenesis studies on OxyR, in which five out of the six mutations that caused DNA 
binding defect mapped near the conserved helix-turn-helix motif proved the role of N-terminal 
domain in DNA-binding52. A truncated version of OxyR in which 22 amino acids were deleted, 
was not capable to function as a regulator indicating that C terminus may also be critical for 
binding52. Random mutagenesis studies showed that the residues important for oligomerization 
are located in the C-terminal domain52. 
 Crystal structures of the regulatory domain of OxyR in oxidized and reduced form are 
analyzed47. Gel retardation assays showed that OxyR is a tetramer in solution52. The structural 
features critical for conversion from reduced to oxidized form were well investigated.  Presence 
of chelators does not affect the capacity of OxyR to activate transcription48. Studies suggest that 
it is unlikely for metals ions and other prosthetic groups to be the redox-active center of OxyR47. 
Mutational studies pointed towards Cys 199 and Cys 208 as redox active centers47,52. Site 
directed mutagenesis studies proved that mutation C199S locks OxyR in reduced state52. Assays 
based on MALDI-TOF and quantitative thiol-disulphide titrations indicated that OxyR is 
oxidized due to formation of an intramolecular disulphide bond between these two active cystein 
residues47,53. Wild type and C199S mutant protein have the same conformation on a non-
reducing gel, suggesting that intermolecular disulphide bridges do not form redox active centers, 
confirming the presence of intramolecular disulphide bonds47. Oxidation of OxyR starts with the 
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initial oxidation of Cys 199 to form a sulphenic acid intermediate which indicates that residues 
Cys 199 and Cys 208 are not equivalent54-56.  
 Structure of the regulatory domain undergoes a significant change when disulfide bond is 
formed. ROS-mediated redox switch is present in each monomer of OxyR. It leads to changes in 
oligomeric interfaces. Fold modifications leading to different tetrameric orientations of OxyR 
result in reorientation of OxyR relative to the DNA. This also could result in presentation of 
RNA polymerase contact sites in an orientation that is favorable to transcriptional activation47. 
 OxyR binds upstream of the promoters it regulates. DNase I footprints for OxyR are 45 
bp long57,58. Studies on seven natural binding sites showed limited homology leading to a 
conclusion that ‘OxyR may have a degenerate recognition code’57,58. Analysis of 54 synthetic 
binding sites allowed researchers to define a consensus binding motif 
(ATAGntnnnanCTATnnnnnnnATAGntnnnanCTAT) for oxidized OxyR. These studies 
suggested that OxyR-DNA binding is based on a specific recognition code58. 
 Hydroxyl radical footprinting and interference assays also showed that the oxidized 
OxyR tetramer binds to the four ATAGxt elements by contacting the DNA in four adjacent 
major grooves. As the key nucleotides are found to be dispersed and both the natural and 
synthetic sites diverge from the consensus motif, it is proposed that OxyR achieves tight, specific 
binding through the four contacts of intermediate affinity58.  
 Footprint of reduced OxyR is longer that that for oxidized OxyR47 indicating that binding 
of OxyR is distinct in oxidized and reduced conditions58. Reduced OxyR contacts two pairs of 
adjacent major grooves separated by one helical turn. In short, whether oxidized or reduced, 
OxyR tetramer contacts DNA at four regions of intermediate affinity. In each region it contacts 
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one to three nucleotides. As cellular redox state changes, OxyR repositions its DNA contacts and 
targets alternate sets of promoters58.  
 OxyR acts as a transcriptional activator of oxidative stress defense genes only for a 
limited period of time 48,59 as activation of OxyR to oxidized state is a transient phenomenon48. 
Genetic and biochemical studies proved that deactivation of OxyR takes place primarily by 
enzymatic reduction by Grx1. The expression of Grx1 and glutathione reductases is induced by 
oxidized OxyR itself. This autoregulation helps to maintain cellular redox balance. Other 
reduction systems also may contribute in vivo48. The process of reduction is slower than the 
oxidation enabling the oxidized OxyR to stay for an extended time under the overall reducing 
environment inside the E. coli cells60. 
 Though, diamide and S-nitroso-Cysteine can react with the two redox active cysteins of 
OxyR, it specifically senses peroxides47. Findings uptill now suggested that OxyR is the sole 
sensor and transducer of oxidative stress in E. coli48. In contrast to this, some recent studies 
stated that endogenous protein S-Nitrosylation in E. coli is under OxyR regulation61.  
1.1.6. P. gingivalis OxyR. P. gingivalis is an example from the class of obligate anaerobic 
bacteria. During transmission from host to host, P. gingivalis being a periopathogen, is exposed 
to atmospheric oxygen, which is the case during their survival in saliva62,63. During this journey, 
unfavorable redox potential and damaging effects of ROS might challenge the survival of P. 
gingivalis. This situation prevails even after P. gingivalis becomes a part of the subgingival 
biofilm. Streptococci like members of this biofilm produce hydrogen peroxide that can freely 
permeate the cell envelopes of neighboring bacteria64. Oxidative stress also originates from host 
defense systems like neutrophils. In short, oxidative stress is ubiquitous in the oral cavity. Hence, 
survival in the presence of oxygen is critical for the virulence and pathogenicity of P. gingivalis62.  
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 Oxygen may induce a very complex effect on an obligatory anaerobe like P. gingivalis. 
Metabolic products of oxygen like superoxide, hydrogen peroxide and hydroxyl radicals 
generally create a high redox environment which might lead to oxidation and inactivation of 
bacterial enzymes. Inactivation of these enzymes is one of the primary reasons for inability of 
anaerobes to survive in the presence of oxygen. Despite the survival challenges posed by oxygen, 
P. gingivalis possesses a robust defense system that makes it aerotolerent63. 
 Genomic sequence of the W83 strain of P. gingivalis shows the presence of oxyR gene, a 
homologue of the putative transcriptional regulator associated with oxidative stress63. A past 
study has shown that P. gingivalis OxyR shares only 30% identity with that of E. coli63. Assays 
done with P. gingivalis W83 strain in which oxyR is inactivated has shown that this strain grows 
normally under anaerobic conditions. Sensitivity of P. gingivalis oxyR mutant towards oxygen 
emphasizes the role of P. gingivalis oxyR gene in bacterial aerotolerence62,{Ohara, 2006 #9.  
 In E. coli and other facultative aerobes and anaerobes, there exists a separate regulator, 
SoxR, for aerotolerence and the regulator OxyR is utilized only for resistance to hydrogen 
peroxide63. The presence of separate regulators is necessary due to complex respiratory 
requirements of those bacteria. In an obligate anaerobe like P. gingivalis, the soxRS regulon is 
absent which entails the two functions, aerotolerence and resistance to hydrogen peroxide to be 
combined in a single protein. Phenotypic characterization of the P. gingivalis oxyR mutant strain 
proved that the regulator OxyR is critical for resistance to hydrogen peroxide as well as for 
aerotolerance63.   
 As discussed in the earlier sections, due to increased concentration of intracellular 
hydrogen peroxide, E. coli OxyR rapidly activates the transcription of OxyS (a small, non-
translated regulatory RNA), katG (hydrogen peroxidase I), gorA (glutathione reductase), grxA 
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(glutaredoxin), ahpC (alkyl hydroperoxidase C) and dps (non-specific DNA binding protein). 
Amongst these, the gene encoding glutaredoxin (grxA) and encoding catalase (katG) is absent in 
PG genome63,65. In PG, the genes ahpFC and dps are regulated by OxyR but they remain 
uninduced by hydrogen peroxide treatment63, instead, their expression increases as a result of 
exposure to atmospheric oxygen62. Other than genes mentioned for E. coli OxyR, the PG oxyR 
regulon also includes PG0421 (encoding a hypothetical protein with no apparent homology to 
other oxidative-stress-related genes), sod (encoding superoxide dismutase which plays a clear 
role in protection against oxidative stress), ftn (encodes ferritin, an iron storage protein) and tpx 
(encodes a thiol peroxidase)62,66. A past study has shown that atmospheric oxygen acts as an 
inducer for these genes, whereas, hydrogen peroxide is not responsible for elevated expression of 
these genes62. The above observation indicates that in P. gingivalis, the stimulus used to induce 
oxidative stress plays a critical role in transcriptional activation of the oxyR regulon. 
 There are very contradictory views about the expression of oxyR regulon in P. gingivalis. 
One view is that in P. gingivalis, expression of oxyR regulon occurs during anaerobic growth and 
is independent of intracellular hydrogen peroxide concentration, suggesting that P. gingivalis 
OxyR does not act as sensor of hydrogen peroxide. Even then the expression of this regulon 
seems to be critical for bacterial resistance to hydrogen peroxide as well as bacterial 
aerotolerence. This constitutive expression of antioxidant genes might be of an advantage for P. 
gingivalis as oxidative stress is ubiquitous in the oral cavity63. Researches are being carried out 
to investigate the reason behind this constitutive activation of P. gingivalis OxyR. A probable 
reason could be the lack of an effective reducing system to maintain OxyR in its reduced form. 
In E .coli, proteins such as glutaredoxin 1 (grxA) and thioredoxin (trxA) reduce OxyR60, among 
which glutaredoxin is the more effective one. PG genome has a homologue of thioredoxin (trxA) 
 13 
which shows 50 % similarity to that of the E. coli analog but homologue of glutaredoxin (grxA) 
is absent63. Another probable reason suggested by investigators is a possibility that P. gingivalis 
possesses OxyR that is locked in the oxidized conformation due to some structural aspects63. The 
above observations suggest that the regulation of genes by P. gingivalis OxyR is different than 
that occurring in E. coli in aspects like the number and types of genes regulated, stimulus for the 
oxidative stress and conditions under which OxyR remains activated.   
 Other investigations demonstrated that in P. gingivalis expression of sod and ahpC which 
was regulated by OxyR was induced by oxidative stress66. It was also observed that the 
expression of ahpC-F, dps, ftn, tpx was OxyR-dependent and increased after atmospheric oxygen 
exposure62. These studies support the other view that the expression of oxyR regulon is not 
constitutive, but this regulon is induced under conditions of oxidative stress only. Hence 
regulation by P. gingivalis OxyR is not well understood and needs further investigation. 
1.1.7. Preliminary data. To study gene regulation by P. gingivalis OxyR microarrays were 
carried out in lab. Wild type P. gingivalis strain and oxyR ko strain were used to analyze gene 
expression. These strains were grown with and without iron (Fe2+) in the growth medium. Wild 
type P. gingivalis strain grown in the media containing iron showed some hints of gene 
regulation which was not exhibited by the oxyR ko strain grown under identical conditions. 
Interestingly, the same regulation was not exhibited by the wild type strain when it was grown in 
a media without iron. These results indicate that apart from OxyR, iron also plays a role gene 
regulation and that OxyR requires iron for regulation of its target genes. 
   This co-regulation is true vice versa also. For example, the hmu operon in P. gingivalis 
is made up of six genes hmuY, hmuR, hmuS, hmuT, hmuU, hmuV. All of these encode proteins 
involved in bacterial hemin uptake. If the surrounding media is rich in hemin, then this operon is 
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down-regulated, whereas, in iron deplete conditions, this operon is up-regulated39,67. Wild type P. 
gingivalis grown under both hemin replete and deplete conditions showed down and up 
regulation of the operon, respectively. It was observed that this regulation was absent in an oxyR 
mutant P. gingivalis strain. The mutant strain was grown in both hemin replete and deplete 
conditions where it was observed that the hmu operon was up-regulated under both the 
conditions, indicating that the regulation was lost. The above observations indicate that iron also 
requires OxyR for regulation of its target genes.   
 These previous studies indicate that some genes are co-regulated by iron and OxyR in P. 
gingivalis suggesting that metals like iron might play a role in OxyR-DNA binding. These 
predictions form the basis of our hypothesis. 
1.1.8. Role of Iron. In the case of P. gingivalis, iron is a main nutrient for this periopathogen39 
and plays a pivotal role in its virulence. Studies have demonstrated that when grown under hemin 
limitation, P. gingivalis were less virulent than their counterparts that were grown in excess 
hemin68-70. Although P. gingivalis can reside at different locations in the oral cavity, bleeding 
periodontal pocket is the most favorite niche for this bacterium, the reason behind this can be 
abundance of iron. Periodontal pockets are bathed in gingival crevicular fluid. Hemoglobin 
present in this fluid, derived from lysed erythrocytes serve as a main source of hemin for 
bacterial uptake39. These pockets are less exposed to atmospheric oxygen compared to other sites 
in the oral cavity. Hence, iron is also available for bacterial uptake in ferrous form which is more 
soluble than its ferric analog.   
 Intracellular iron concentration has a connection with oxidative stress experienced by the 
bacteria. Iron has a tendency of getting oxidized and reduced readily. This capability of iron 
makes it biochemically dangerous, because free iron in the form of ferrous ion is capable of 
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undergoing Fenton reaction which converts hydrogen peroxide into harmful free radicals39. 
Though iron and hemin are critical for growth and virulence of P. gingivalis, keeping a check on 
the intracellular free iron concentration is also important.   
 In micro-organisms, 10-20% of all genes are regulated by intracellular iron concentration 
and P. gingivalis is not an exception. An alteration in the expression of 71 genes was observed 
when grown in iron limited conditions, many of which were related to iron uptake-storage, 
adhesion with the host cells, biofilm formation and many were genes of unknown function39. The 
genes which were down-regulated in iron limited conditions included genes encoding proteins 
implicated in iron storage and those involved in oxidative stress defense. Some of the genes like 
a gene encoding Dps (ferritin like protein), gene encoding Ftn (ferritin), gene encoding 
rubrerythrin, were of special interest as they also come under oxyR regulon. Dps comes under 
OxyR regulon and is proved to be required for protection against oxidative stress71. The protein 
rubrerythrin is predicted to be indispensable for the protection of P. gingivalis from oxidative 
stress72. Genes induced by oxidative stress are down-regulated in iron deplete conditions39 
indicating a connection between oxidative stress, OxyR and iron.   
 1.1.9. Present research. Based on the preliminary studies, the goal of this present study is to 
determine the binding mechanism of OxyR to DNA and to establish the hypothesis that metals 
are involved in OxyR-DNA binding. This research encompasses the following investigations:  
1. Determination of the DNA sequence binding site for OxyR 
2. Establishing the role of metals in OxyR-DNA binding 
3. Role of specific amino acids in DNA binding 
4. In-vivo characterization of OxyR-DNA binding 
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1.1.10. Principle and significance of in vivo characterization.  Recently, in vivo kinetics behind 
specific binding of a transcription factor, lac repressor (LacI) to a chromosomal lac operator was 
studied by Elf et al.73  For imaging purposes, lac repressor was tagged with a rapidly maturing 
fluorescent protein (YFP) at its C-terminus. The fusion protein was expressed from the native 
chromosomal lacI locus. C-terminal fusion is preferred over N-terminal fusion to avoid 
interference with N-terminal DNA-binding domain. To detect association-dissociation of LacI 
with its target binding site, lac operator on the E. coli genome, E. coli cells were imaged with a 
wide field fluorescence microscope and a charged-coupled device (CCD) camera in presence and 
absence of IPTG. The presence of IPTG substantially reduces the affinity of LacI to lac operator 
resulting in dissociation of LacI from lac operator.74  It was observed that in the presence of 
IPTG, when the LacI was not bound to the lac operator, a diffuse fluorescent signal was detected 
from the entire area of the cell. In absence of IPTG, when LacI was bound to lac operator sharp 
fluorescent spots were observed. 
 These studies established the basic concept that if a fluorescently tagged transcription 
factor is not specifically bound to DNA, it emits fluorescence from the entire area of the cell due 
to its fast diffusion. When the transcription factor is bound specifically to relatively stationary 
DNA fragment, it emits from a highly localized region.75 This phenomenon is referred as 
fluorescence due to localization enhancement. 
 Based on this concept, fluorescently tagged OxyR will produce sharp fluorescent spots 
when bound to target DNA sequences whereas, a diffused signal will be obtained for unbound 
OxyR. This phenomenon allows investigation of the conditions under which P. gingivalis OxyR 
binds to its target DNA sequences present on P. gingivalis genomic DNA, by direct visualization 
of binding.  By keeping this idea in mind the ultimate goal of in vivo characterization is to 
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investigate P. gingivalis OxyR-DNA binding by growing the cells under different conditions like 
in the presence and absence of metals and EDTA in the growth media. These experiments would 
allow us to validate the results obtained through in vitro characterization and to confirm the role 
of metals in OxyR-DNA binding. By using this technique, it is also possible to compare if the 
fluorescently tagged P. gingivalis OxyR and fluorescently tagged E. coli OxyR bind to their 
respective target sequences under similar conditions.  Direct visualization of in vivo binding is 
the best technique to study binding mechanism of a transcription factor to its target sequences, 
since it nullifies the need of extrapolating the results obtained by in vitro experiments where the 
experimental conditions may not be the replica of intracellular atmosphere. 
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1.2 Materials and methods. 
  
1.2.1. Constructs used. Construct A was made in the lab by cloning sequence encoding P. 
gingivalis OxyR from P. gingivalis genomic DNA in to pFC20K T7 SP6 Halo Tag Flexi Vector 
(Promega) in place of barnase gene. Protocol given in the technical manual of Flexi vector 
system was followed for cloning. An erythromycin resistant cassette, ermF-ermAM (Fletcher) 
was inserted downstream of HaloTag sequence at EcoRI/XbaI. A sequence encoding ssb gene 
from P. gingivalis genomic DNA was inserted downstream of the ermF-ermAM at XbaI/SalI. A 
site directed mutagenesis was 
performed on plasmid DNA from 
construct A to prepare construct 
B and C. A QuickChange 
Lightening Site-Directed 
Mutagenesis kit (Agilent 
technologies) was used. 
Construct D was prepared by 
cloning sequence encoding OxyR 
from E. coli genomic DNA in to 
pFC20K T7 SP6 Halo Tag Flexi 
Vector (Promega) in place of 
barnase gene.  
1.2.2. Protein expression and purification. To express wild type P. gingivalis OxyR, mutant 
OxyR-C199S, mutant OxyR-H17A and wild type E. coli OxyR along with a Halo tag at the C-
terminus, constructs A, B, C, D were used respectively. These constructs were transformed in E. 
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coli BL21(DE3) expression cells and the transformed strains were named as V3080, V3082, 
V3099 and V3107 respectively. These strains were used for protein purification. The cultures for 
all the strains were treated in a similar manner as mentioned ahead. A 50 ml LB media 
containing 25 µg/ml Kanamycin and 100 mg of glucose was inoculated with the transformants 
growing on a fresh LB-Kanamycin plate. This media was left in the shaker at 37°C for 12-16 
hours. This 50 ml media was used to inoculate 500 ml LB media containing 25 µg/ml 
Kanamycin and 1 gm of glucose. Media was left in the shaker at 37°C till the optical density 
reaches 0.6. 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) was added to induce the protein 
expression. The media was left in the shaker at 37°C overnight after addition of IPTG. For 
harvesting the pellet and further purification, Halo Tag protein purification system protocol 
(Promega) was followed.   
1.2.3. Running a protein gel. The purified protein samples were run on a NuPage12% Bis-Tris 
gel (Invitrogen). Samples were run under two conditions, non-reducing and reducing. Under 
non-reducing conditions, protein samples were mixed with NuPage LDS sample buffer (4X) and 
loaded on the gel. Under reducing conditions, NuPage LDS sample buffer (4X), Invitrogen-
reducing agent (10X) were added in the protein sample of interest, heated on near boiling water 
bath for 10 minutes before loading on the gel. Gels were run at 200V. 
1.2.4. Preparation of cell lysates. For preparation of cell lysates for P. gingivalis  wild type 
OxyR, P. gingivalis mutant OxyR-C199S and P. gingivalis mutant OxyR-H17A, strains V3080, 
V3082 and V3099 are utilized respectively. A 5 ml LB media, containing 25 µg/ml Kanamycin 
was inoculated with the desired strain. The culture was left in the shaker at 37°C till the optical 
density reaches 0.6. Half of the culture was stored on ice till isolation of the pellet. This pellet 
was used to prepare the un-induced cell- lysate. The remaining half of the culture at optical 
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density 0.6 was induced by addition of 1 mM IPTG and left in the shaker at 37°C for four hours. 
Pellet was harvested. This pellet was used to prepare induced-cell lysate. Pellets for un-induced 
and induced lysates were washed twice with 1X PBS. The cultures were placed in Lysing matrix 
tubes (MP Biomedicals). For breaking the cells Fastprep-24 (MP Biomedicals) was used twice 
for 30 second at the speed of 6. Samples were spun down at 13,000 RPM, 4°C for 5 minutes in a 
table top centrifuge. Supernatants were directly used for EMSA. 
1.2.5. Preparation and purification of in vitro protein. TNT Quick Coupled 
Transcription/Translation System protocol was followed for in vitro protein production.  
This process requires a plasmid DNA in which sequence encoding the protein of interest is 
cloned downstream T7 promoter. For P. gingivalis wild type OxyR, plasmid DNA isolated from 
strain V3080 was used. Similarly for mutant proteins C199S and H17A, plasmid DNA isolated 
from strains V3082 and V3099 were utilized respectively. 
The entire 50 µl transcription-translation reaction was treated as 10 ml cell culture and Halo Tag 
Protein Purification system protocol was followed with some modifications. For example, after 
incubation with TEV protease, supernatant was not applied to the His-link resin obtained with 
the kit. Instead, the 5 mM zinc was added to the supernatant to inactivate TEV protease. This 
supernatant is used to set binding reaction of EMSA. 
1.2.6. Labeling the DNA probes for EMSA. DNA probes that are to be used for EMSA were 
amplified by PCR from P. gingivalis W83 genomic DNA and E. coli BL21(DE3) genomic DNA 
as per the requirement. Refer to list of primers 1 for primer sequences and size of the fragments 
amplified.  PCR amplified probes were purified using PCR purification kit (Quiagen). Biotin 3’ 
End DNA Labeling Kit (Thermo-Scientific) was utilized to label the probes. Approximately a 
little less than 5000 nM of the purified fragments were used for one labeling reaction (50 µl).  
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Volume of the labeled DNA used for binding with the protein was different in each assay as 
mentioned in result section.   
1.2.7. Binding conditions used for EMSA. EMSAs were carried out under two different binding 
conditions. Under condition A,  the  components added were 2 µl of 10X binding buffer, 1 µl of 
poly (dI.dC), 1 µl of 50% glycerol, 1 µl of 1% NP-40, 1 µl of 1M KCl, 1 µl of 100mM MgCl2, 1 
µl of 200 mM EDTA, 1 µl of 1X BSA in a total of 20 µl of binding reaction (These components 
were provided along with the Chemiluminiscent EMSA binding reaction kit by Promega) . 
Under condition B, NP-40 and glycerol were excluded and Tween-20 (final concentration = 1%) 
was added to the binding reaction.  
1.2.8. Running gel for EMSA and transfer to the Nylon membrane. For running the binding 
reaction on a gel, 6% Polyacrylamide as well as Agarose gel is used depending on the size of the 
probe. Whenever samples were run on a polyacrylamide gel, protocol from the Instructions 
manual of Lightshift Chemiluminiscent EMSA kit (Thermo Scientific) was followed for gel 
running and transfer. When agarose gel is used, 1X TBE buffer is used as a running buffer. After 
electrophoresis, gel is soaked in denaturing buffer for half an hour followed by soaking in 
neutralizing buffer for an hour. Transfer to Amershan Hybond – N+ membrane (GE Healthcare) 
is achieved under gravity by keeping the gel and the membrane in contact with each other for 
about 10 hours. Denaturing buffer was prepared by adding 8 gm of sodium hydroxide and 35 gm  
of sodium chloride to water and final volume was adjusted to 400 ml. Neutralization buffer was 
prepared by adding 30.8 gm of ammonium acetate and 320 mg of sodium chloride to water and 
final volume was adjusted to 400ml.   
 22 
1.2.9. Detection by chemiluminiscence. Once the transfer is accomplished, the membrane is UV 
crosslinked (Stratagene 2400) and DNA signal is detected by chemiluminiscence using 
Lightshift Chemiluminiscent detection module (Thermo Scientific).  
1.2.10. CHIP-chip assay. To determine the target binding sites present on P. gingivalis genomic 
DNA for P. gingivalis OxyR, CHIP-chip assay was performed in the lab by Sai Yanamandra. For 
that, construct A mentioned in section 1.2.1 was utilized. This construct was electroporated in P. 
gingivalis W83 after linearization.  Incorporation of C-terminally tagged P. gingivalis OxyR into 
P. gingivalis genomic DNA by homologous recombination, was confirmed by genomic DNA 
sequencing. This recombination led to the expression of P. gingivalis OxyR along with a 
HaloTag from genomic DNA and its subsequent binding to the target sites present on the 
genomic DNA.  OxyR bound to the target sites on the genome was cross-linked. A resin that 
binds covalently with the tag was used to pool this cross-linked OxyR. Protocol for the Halo-
CHIP system (Promega) was followed to pool OxyR and to purify the bound genomic DNA 
fragments after releasing the cross-links. The purified fragments were utilized for whole genome 
amplification and library generation. Microarrays were performed which provided a list of 
fragments (Refer table 1) bound to the 
transcriptional regulator OxyR.    
1.2.11. Construction and working of a 
microfluidic flow plate for bacteria (ONIX-
CeLLASIC system). Microfluidic plates are 
suitable for bacterial live cell microscopy. 
B04A plate fits to a typical microscope stage 
holder. The microfluidic chambers on the 
 
          A 
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plates hold the bacterial cells in a single focal plane and they can be tracked over multiple 
generations for >12 hours. The design of the plate is as shown in the diagram A (Images A, B 
and C: courtesy 
www.cellasic.com). Rows A-D 
on the plate are 4 independent 
flow units. Each unit has 8 
wells including 5 inlets for 
adding media (1-5), cell outlet 
(6), waste (7) and cell inlet (8) 
from which culture can be 
introduced in the plate. Each independent flow unit has 6 trap regions (1-6) each having different 
dimensions as shown in diagram B. The cell-loading in these trap regions is a two step process. 
In the first step, flow from well 8 to 6 transports the cell culture loaded in cell-inlet well 8 into 
the bottom flow channel. The 
next step is to pressurize both 
well 6 and 8 to drive cells into 
the 6 trap regions. The cells 
will get trapped in the trap 
channels depending on their 
size. For application of this 
pressure the lid of the plate is connected to a CeLLASIC unit as shown in the diagram C. 
Precision laminar flow creates a stable cell environment resulting in minimal stress on cells. 
B04A plate allows 5 different solution changes during one experiment as there are 5 inlet wells 
 
 
           B 
 
 
 
    C 
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for the media in one flow channel. CellASIC FG Software allows programming automated 
perfusion protocols for precise change in the media at the desired time point. It is possible to 
record cell response to media change during high magnification imaging.  
1.2.12. Culture preparation for approach 1. A 5 ml LB media containing 25 µg/ml Kanamycin 
was inoculated with strain V3080 from a freshly streaked plate. Culture was allowed to grow at 
37°C for 18 hours. After the incubation period, the culture was diluted by a factor of 10. 50 µl of 
the diluted cell culture was put in well 8 of the independent flow channel A of the microfluidic 
plate. The composition of the media added in all the inlet channels 1-5 was not same. In well 1 
and well 2, 300 µl of LB media was added. In wells 3-5, 300 µl of LB media containing 1X Halo 
Tag ligand and 1mM IPTG was added. The dilutions of the HaloTag ligand were made as per the 
technical manual of HaloTag Technology: Focus On Imaging (Promega).  The media in which 
the cells were bathing was changed after each hour such that the cells were bathing in the media 
from inlet 1 for first one hour, then in the media from inlet 2 for the next one hour and so on. All 
the instrumental set up was made as mentioned in the B04A Application Note for Dynamic Live 
Cell Imaging For Bacteria (CeLLASIC). Images were captured using Zeiss Cell Observer 
Spinning Disc Microscope after every 15 minutes for 5 hours.  
1.2.13. Design of strategy 1 for approach 2. pGLOW-Bs2-Stop(pUC18) vector bought from 
‘evocatal’ had the fluorescent protein in a pUC18 vector which was unsuitable for expression. To 
construct and express a fusion protein it was necessary to clone pGLOW-Bs2 from pUC18 
downstream and in frame with P. gingivalis OxyR already present in Flexi vector (plasmid DNA 
V3080). In this plasmid V3080 ‘HaloTag coding sequence’ was present downstream P. 
gingivalis OxyR. Our cloning strategy was based on replacement of the HaloTag coding 
sequence with the sequence encoding pGLOW-Bs2. To achieve this aim, plasmid DNA V3080 
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should be digested with restriction enzymes Xhoi, EcoRi which will digest out the HaloTag 
protein coding sequence. pGLOW-Bs2 coding sequence then can be inserted in between these 
restriction sites in frame with the OxyR present upstream. For this purpose a new construct was 
made from original pGLOW-Bs2-Stop (pUC18) bought from the company in the lab. This new 
construct was made by inserting some new sequences and deleting some existing sequences from 
the original pUC18 vector that contained pGLOW-Bs2-Stop as explained ahead. T7 promoter 
sequence, multiple cloning sites, and the sequence encoding TEV protease all taken from 
pFC20K HaloTag T7 SP6 Flexi vector were cloned upstream the start codon for pGLOW-Bs2 in 
pUC18 vector. This resulted in insertion of Xhoi recognition site upstream pGLOW-Bs2 start 
codon in the pUC18 vector. At the end of the coding sequence for Bs2 there was a Xhoi 
recognition sequence CTC GAG encoding Leucine and Glutamic acid. Presence of this sequence 
was undesirable for our cloning strategy. Hence this sequence was deleted keeping the Stop 
codon downstream intact. EcoRi recognition sequence was inserted downstream the stop codon.   
1.2.14. Xhoi/EcoRi double digestion. Plasmid DNAs or amplified PCR products were digested 
using Xhoi, EcoRi, NEB 10X buffer 2, 100X BSA and water. Concentrations of the DNA to be 
digested and the restriction enzymes used, was adjusted according to the NEB guidelines for 
digestion. The digestion reactions are incubated at 37°C for 2 hours and then run on agarose gel 
of desired concentration according to the size of the DNA fragment digested. 
1.2.15. Gel extraction, ligation, transformation. A Quiagen gel extraction kit was used to excise 
and extract the desired bands from the gel. Flexi ligation kit (Promega) was used and ligation 
protocol from the technical manual for Flexi vector systems (Promega) was followed. Ligation 
reactions were transformed in E. coli XL-10 ultracompetent cells following the protocol 
provided by Invitrogen.  
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1.2.16. Culture preparation for the construct made by strategy 1. To check the expression by 
fluorescence, the newly ligated construct mentioned in section 1.4.2.I. was transformed into E. 
coli BL21(DE3)  expression cells (Invitrogen). The transformed cells were used to inoculate 5 ml 
LB media containing 25 µg/ml of kanamycin. The culture was left in the shaker at 37°C for 18 
hours. After dilution by a factor of 10 the culture was allowed to grow till the O.D. reaches 0.6 
and then induced by adding 1mM IPTG. Culture was again left in the shaker at 37°C for 4 hours 
after induction. 10 µl of this culture were directly put on a microscope slide and a cover-slip was 
put. The culture was observed under a fluorescent microscope once the culture was dry.  
1.2.17. Design of constructs for strategy 2 approach 2. Under strategy 2, three constructs were 
made. For making these constructs, it was planned to make use of the plasmid DNA isolated 
from strain V3107 (which expresses E. coli OxyR tagged to 
a HaloTag protein) and the plasmid DNA isolated from the 
strain V3080 (which expresses P. gingivalis OxyR tagged 
to a HaloTag protein) Construct P was designed as shown 
in the adjacent diagram. AGGAGA is the RBS for E. coli. It 
was planned to make construct P by replacing HaloTag in 
V3107 plasmid. Similarly by replacing HaloTag in V3080 
plasmid DNA construct Q could be made. Constructs P and Q could be transformed in E. coli 
BL21(DE3) cells to monitor expression of E. coli OxyR and P. gingivalis OxyR respectively in E. 
coli cells and to visualize their binding to E. coli genomic DNA under different conditions for 
comparison of the binding mechanisms. Design for construct R was similar to that of construct Q 
except that in place of E. coli RBS, P. gingivalis RBS was planned to be inserted to allow the 
expression of the fusion protein and visualization of its binding inside P. gingivalis cells.   
P
Q
R
Bs2AGGAGAPG oxyR
Flexi vector
Bs2AAGAAA
Flexi vector
PG oxyR
Bs2AGGAGAEC oxyR
Flexi vector
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            1.2.18. Amplification of inserts for strategy 2. For 
amplification of inserts for strategy 2, plasmid 
pGLOW-Bs2-Stop (pUC18) (evoglow) was used as a 
template for PCR.  To amplify inserts to clone in 
constructs P and Q the sequence of the forward 
primer (FP1) used was - 
GAGCTCTCGAGTGAGGAGATATGGCGTCGTTCCAGTCGTTCGGCATCCCG. This 
primer inserted the Xhoi site and the sequence encoding E. coli RBS upstream of the start codon 
of pGLOW-Bs2. The primer sequence was designed in such a way that pGLOW-Bs2 will be in 
frame with OxyR after cloning. The sequence of the reverse primer (RP) used for insertion in 
these constructs was – CTGACTGAATTCTCATTCAAGCAGCTTTTCATATTCCTTCTG. 
This reverse primer was designed to insert EcoRi recognition sequence downstream the stop 
codon of pGLOW-Bs2. In the sequence encoding Bs2, the last two codons are CTC GAG 
encoding amino acids Leucine and Glutamic acid respectively. As CTC GAG is recognition 
sequence for Xhoi, these codons were changed to CTT GAA again encoding amino acids 
Leucine and Glutamic acid, respectively. This resulted in the elimination of Xhoi recognition 
sequence present at the end of bs2 encoding sequence as it was unsuitable for the planned 
cloning strategy. For insertion into construct R, sequence of the forward primer (FP2) used was 
GAGCTCTCGAGAAATAAGAAACAATTATGGCGTCGTTCCAG. This was designed to 
insert Xhoi site and P. gingivalis RBS upstream the start codon of Bs2. Primer design was to 
keep Bs2 in frame with OxyR. A total of three inserts, two amplified with primer pair FP1-RP 
and one amplified with primer pair FP2-RP were run on the gel to check the size of the PCR 
product. Inserts amplified with FP1-RP were used for ligating with vectors V3107 and V3080 
Flexi vector
Halo tagoxyR EcoRi
Xhoi
Acceptor vectors
V3015, V3106
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after digestion to make constructs P and Q, respectively. Insert amplified with FP2-RP was 
ligated with Vector V3080 post digestion to make construct R.   
1.2.19. TOPO cloning. Insetrs were amplified with primer pairs FP1-RP and FP2-RP using 
pGLOW-Bs2-Stop(pUC18) (evoglow) as template. These PCR products were purified using 
Quiagen PCR purification kit and cloned into TOPO2.1 PCR vector (Invitrogen) by following 
the ligation protocol provided in the technical manual for TOPO vectors (Invitrogen). 
1.2.20. Construction of a positive control vector. The sequence encoding pGLOW-Bs2 was 
cloned downstream the T7 promoter in the present in Flexi vector replacing the barnase gene. 
pFC20K halo Tag T7 SP6 Flexi vector was available from promega as shown in G. 
 
 
 
 
 
 
 
The aimed positive control construct is as shown in E.  pGLOW-Bs2 coding sequence was 
amplified from pGLOW-Bs2-stop(pUC18) vector from evocatal basic kit with forward primer 
having sgfI site and reverse primer having pmeI site. Sequence of the forward primer used was 
5'-ATATGCGATCGCCATGGCGTCGTTCCAGTCGTTC-3' and sequence of the reverse 
primer used was 5'- GGTTGTTTAAACTCACTCGAGCAGCTTTTCATATTCCT. Purified and 
amplified PCR product and the Flexi vector were digested and ligated by following the protocol 
barnase HaloTag
Flexi vector
SgfI EcoiCRi
T7
 
 
                                  G 
 
 
SgfI
pGlow- Bs2 HaloTag
Flexi vector
T7
 
                                 
                                  E 
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mentioned in the ‘Technical manual of Flexi Vector Systems.’  After colony screening, plasmid 
DNA was isolated and sent for sequencing. 
1.2.21. Culture treatment for controls. The positive control construct was transformed into E. 
coli BL21(DE3) expression cells (Invitrogen). A 5 ml LB media containing 25 µg/ml Kanamycin 
was inoculated with those transformed cells and left in the shaker at 37°C for 18 hours. The 
culture was diluted by a factor of 10 and again left in shaker at 37°C till O.D. reaches 0.5-0.7. 
The culture was divided in three parts and 0.2 mM, 0.4mM and1 mM IPTG was added in them to 
induce protein expression.  All the three induced cultures were left in the shaker at 25°C for 18 
hours. The culture was spun at 6000 RPM for 5 minutes at 4°C. The pellet was re-suspended in 1 
ml of 1X PBS buffer and 10 µl of that was put on microscope slide and a cover-slip was put. The 
slide was observed under the fluorescent microscope once the culture dried. A culture for strain 
V3080 was also grown and induced under the same conditions as mentioned above for the 
positive control construct and used as a negative control. 
1.2.22. Camera settings. Nurolucida camera settings used were, for DIC 55 ms, gain 2, for CFP 
and DAPI 1200 ms, gain 6, for GFP and DsRed 700 ms, gain 4. In all cases offset was 4. 
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1.3 Results of in vitro characterization 
1.3.1 Selection of DNA fragments to check OxyR binding. In vitro characterization of binding 
of P. gingivalis OxyR to genomic DNA, starts with the prediction of sites present on the P. 
gingivalis genomic DNA which act as target binding sites for P. gingivalis OxyR. For this 
prediction, a CHIP-chip assay was carried out in the lab by Sai Yanamandra as mentioned in the 
materials and methods section. This assay provided a list DNA fragments which were found to 
be the target binding sites for P. gingivalis OxyR (Refer to table 1). These fragments were 
amplified from the P. gingivalis genomic DNA by PCR (Refer to list of primers 1 for primer 
sequences), purified and labeled as mentioned in the materials and methods section for their use 
in electrophoretic mobility shift assays (EMSA). Microarray studies mentioned in preliminary 
studies section indicated that rbr and hmu fragments are also the target binding sites for P. 
gingivalis OxyR. Along with these fragments a few more fragments reported to bind with P. 
gingivalis OxyR in literature are used for EMSAs. They include sod62,66 (encoding superoxide 
dismutase), ahpc62 (encoding alkyl hydroperoxidase C). Three different regions from sod 
fragment and two different regions from the ahpc fragments were amplified with respective 
primers for their use in EMSA. Fragment is is the predicted binding site for E. coli OxyR61, 
hence it is also used whenever E. coli OxyR was used for EMSA. (Primer sequences for all the 
DNA fragments are as mentioned in list of primers 1).  
1.3.2 Optimizing conditions for EMSA EMSAs were performed to validate the results obtained 
by CHIP-chip assay. Conditions under which EMSAs can be performed include several variables 
like design of the nucleic acid target, purification of protein to be used for binding, binding 
reaction components, incubation span and temperature for the binding reaction and  
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Table 1. List of DNA fragments from CHIP-chip assay. 
 
    Gene bank locus tag           Definition 
PG0360 LemA protein (conserved 
hypothetical protein)  
PG1863 Hypothetical protein 
PG1862 Hypothetical protein 
PG0304 Electron transport complex 
PG1240 conserved hypothetical protein 
(probable transcription regulator)  
PG1307 glucose inhibited division protein B 
(glucose-inhibited division protein B) 
PG0964  (CDP-diacylglycerol-serine-O-
phosphatidyltransferase)    
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electrophoresis conditions. These variables need to be optimized for each molecular system76. 
1.3.2.I. EMSA control reaction under two different binding conditions.  As mentioned in the 
materials and methods section, two different conditions A and B were utilized to set binding 
reactions. Condition B differs from condition A as B does not contain glycerol and NP-40, 
instead Tween 20 was added in the binding reaction. Role of glycerol is to stabilize labile 
proteins and also to enhance the stability of protein-DNA complexes. Non-ionic detergents such 
as NP-40 and Tween 20 help to maximize protein solubility76. It was observed in the lab earlier 
that replacement of glycerol and NP-40 by Tween-20, increased the clarity and sharpness of the 
signal obtained. On the other hand, under this condition B, total absence of glycerol in the 
binding reaction might decrease the stability of DNA-protein complex to give false negative 
results. Hence it was decided to try EMSAs under both the binding conditions. For that, EMSA 
was carried out on the as received control samples under both the conditions. Control reactions 
were carried out as per the protocol given in the instructions manual of Lightshift 
Chemiluminiscent EMSA kit (Thermo Scientific).  Binding reactions were run on 6% 
polyacrylamide native gel (Invitrogen). Transfer and detection were performed as mentioned in 
the materials and methods section.     
 Lane 1 in figure 1A and B, containing only labeled DNA marks the position of unbound 
DNA fragment on the gel. Second lane shows a band of less mobility indicating the formation of 
DNA-protein complex. This band of less mobility disappears in the third lane indicating that 
protein does not bind to the labeled DNA fragment when excess of unlabeled specific competitor 
was added to the binding reaction prior to the addition of the labeled fragment. Figure 1 shows 
that control reaction carried out using commercially available products worked as expected under  
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Figure 1. EMSA of the as received protein and 
DNA fragment performed under two different 
conditions, A and B, as mentioned in the text. 
Lane 1 – Biotin-EBNA control DNA, Lane 2 - 
Biotin-EBNA control DNA+ EBNA extract, 
Lane 3 - Biotin EBNA control DNA+ EBNA 
extract+ 200-molar excess of unlabeled EBNA 
DNA. 
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both the binding reaction conditions. The next step was to try EMSAs using the protein of 
interest and its target DNA fragments.  
1.3.2.II Making different protein preparations for EMSA. 
1.3.2.II A. In vivo protein expression and Purification.  Wild type P. gingivalis OxyR and 
OxyR mutants C199S and H17A were expressed in E. coli cells and purified simultaneously as 
mentioned in the materials and methods section. The final yields for purified wild type protein 
preparations, mutant C199S and mutant H17A were 0.9mg/ml, 0.55 mg/ml and 0.04 mg/ml 
respectively. A 12% Bis-tris gel was run to check the purity of the protein preps. (Figure 2). 15µl 
of each of the preparations were loaded on the denaturing gel under non-reducing conditions. 
(Refer to materials and methods section for details on sample preparation.)  
 In figure 2, Lane 4 in panels A, B and C contains the purified protein. A single band of 50 
kDa was observed for all the three purified protein preparations indicating that the preparations 
did not contain any other proteins than the one of interest. Although the size of Size of P. 
gingivalis OxyR is 35 kDa and that of E. coli OxyR is 33 kDa, of the band observed for all the 
three protein preparations was of  50 kDa size. This could be due to intra-molecular disulfide 
bond formation.  
1.3.2.II.B. Preparation of crude protein lysates.  Instead of purified proteins, crude cell lysates 
were used for binding with the DNA fragments of interest. Un-induced and induced cell lysates 
were prepared for wild type P. gingivalis OxyR as well as for mutant OxyR proteins C199S and 
H17A as mentioned in the materials and methods section. Lysates for wild type protein and 
lysates for mutant proteins were not prepared simultaneously. 
1.3.2.II.C. Preparation of in vitro transcribed OxyR. Wild type P. gingivalis OxyR and OxyR 
mutant proteins C199S and H17A were made in vitro by using in vitro transcription-translation  
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Figure 2. SDS-PAGE gel image for the in vivo expressed and purified P. gingivalis 
OxyR wild type (A), OxyR mutant C199S (B), OxyR mutant H17A (C); where Lane L 
– Novex sharp pre-stained ladder (Invitrogen), Lane 1 – Cell lysate, Lane 2 – Flow 
through, Lane 3 – Resin wash, Lane 4- Elution 1.    
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kit and purified as mentioned in the materials and methods section. To check the size and purity 
of the in vitro transcribed protein, 30 µl of the wild type in vitro OxyR preparations made in the 
subsequent batches were run on 12% Bis-tris denaturing gel under non-reducing conditions. 
(Figure 3) A band of 50 KD was observed for in vitro wild type OxyR preparations from batch 2, 
3 and 4. An undesired band of 15 kDa was also observed for all the three preparations. 
1.3.3. Binding of OxyR to selected fragments. 
1.3.3.I. EMSAs using purified proteins. Wild type OxyR and mutant proteins C199S and H17A 
purified after in vivo expression (Refer section 1.3.2.II.A) were used to bind with rbr fragment 
amplified from P. gingivalis genomic DNA (Primers sequences are mentioned in the list of 
primers 1) after purification and labeling of the fragment as mentioned in materials and methods 
section. 5 µl of the labeled DNA fragment was utilized for binding with 1 µg of each of the 
above mentioned protein preparations under two different binding conditions A and B mentioned 
in materials and methods section. The binding reactions were run on a 3% Agarose gel. Figure 4 
shows that all the DNA fragments, those which were not incubated with the protein and those 
which were incubated with protein had the same mobility indicating that none of the proteins 
incubated with labeled rbr fragment were able to bind to the fragment.  
 Wild type purified OxyR was used to perform EMSAs with different DNA fragments 
amplified from P. gingivalis genomic DNA, which were the predicted binding sites for wild type 
OxyR. Three different parts of the sod gene were used for EMSAs (Refer section 1.3.1 for 
details)(Figure not included). CHIP-chip assay listed genes PG0964 and PG0360 as probable 
binding sites. So these were also used for EMSAs (Figure not included).None of these binding 
reactions showed a shift in the position of the DNA fragment after incubating predicted OxyR  
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Figure 3. SDS-PAGE gel image of the 
in vitro transcribed P. gingivalis OxyR 
from different batches, where Lane 1 – 
Novex sharp pre-stained ledder 
(Invitrogen), Lane 2-4 – In vitro 
transcribed wild type P. gingivalis 
OxyR from batches 2, 3 and 4 
respectively.  
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Figure 4. EMSA using (rbr) DNA fragment with 
the purified proteins, where lanes 1-4 - condition 
A and lanes 5-8 -  repetition of lanes 1-4 under 
condition B. Lane 1 - rbr DNA only, Lane 2 – rbr 
DNA+ Wt. OxyR, Lane 3 - rbr DNA+  OxyR 
mutant C199S, Lane 4 - rbr DNA+ OxyR mutant 
H17A  
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binding DNA fragments with the wild type P. gingivalis OxyR protein suggesting that purified P. 
gingivalis OxyR does not bind to the predicted DNA sites. 
1.3.3.II. EMSAs using crude protein extract for wild type OxyR . Different amounts of crude 
protein extracts prepared for wild type OxyR were used to perform EMSAs. First, 3 µl of lysates 
were used to bind with 5 µl of labeled DNA fragments sod part 3 and PG1240 IFF,IFR (For 
primer sequences, refer to the list of primers 1) (Figure 5). 5.5 µl of lysates were used to bind 
with 5 µl of labeled fragments PG0964, PG0304 and PG1307 (For primer sequences refer to the 
list primers 1) (Figure 6).  All these EMSAs were carried out under condition B mentioned in 
materials and methods section. The binding reactions were run on a 1% Agarose gel. 
  In figure 5 and 6, lane 1 marks the position of the unbound DNA. In lane 2, un-induced 
lysates served as negative controls as there is no change in the mobility of the DNA fragments 
after incubation with the un-induced lysates. Lane 3 indicates that the mobility of the fragments 
used, decreased after incubation with the induced lysates suggesting formation of a protein-DNA 
complex with all the DNA fragments used.  
1.3.3.III. EMSA using in vitro wild type OxyR. 3.12 µg of the wild type OxyR protein purified 
after producing it in vitro, was used for binding with 5 µl of labeled DNA fragments. DNA 
fragments PG0964, PG1307, PG0304, PG1240 F,R, PG1240 IFF, IFR, PG1862 IFF, IFR and 
PG0360 were used (Refer to table 1 and the list of primers 1 for details). EMSAs were carried 
out under condition B. The binding reactions were run on a 1% Agarose gel.   
 Figure 7 shows the image of the EMSA using different DNA fragments. For each 
fragment the first lane marks the position of the unbound DNA fragment. For all the DNA 
fragments shown in figure 7, the mobility decreased after incubation of the respective fragments 
with the wild type protein indicating the formation of a protein-DNA complex in each case.  
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Figure 5. EMSA using wild type OxyR cell 
lysates (volume – 3 µl) with DNA fragments 
PG1240 (A) and sod 3(B), where, Lane 1 – 
DNA only, Lane 2 – DNA+ un-induced 
OxyR cell lysate, Lane 3 – DNA+ Induced 
OxyR cell lysate.  
 
 
 41 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1       2       3
A B C
1       2       3 1       2       3
 
 
Figure 6. EMSA using wild type OxyR cell lysates 
(volume – 5.5 µl) with DNA fragment  PG0964 (A), 
PG0304 (B) and PG1307 (C) where, Lane 1 – DNA 
only, Lane 2 – DNA+ un-induced OxyR cell lysate, 
Lane 3 – DNA+ Induced OxyR cell lysate. 
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Figure 7. EMSA using In vitro transcribed wild type OxyR with different 
DNA fragments, where, Lane 1 - DNA only (PG0964), Lane 2 - DNA + 
OxyR, Lane 3 - DNA only (PG1307), Lane 4 - DNA + OxyR, Lane 5 - DNA 
only (PG0304), Lane 6 - DNA + OxyR, Lane 7 - DNA only (PG 1240 F,R), 
Lane 8 - DNA + OxyR, Lane 9 -  DNA only (PG 1240 IFR, IRR), Lane 10 - 
DNA + OxyR, Lane 11 - DNA only (PG1862), Lane 12 - DNA + OxyR, 
Lane 13 - DNA only (PG0360), Lane 14 - DNA + OxyR. 
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Decrease in mobility was apparent in the form of smears but no distinct band of less mobility 
was observed for any of the fragments. This may be due to partial dissociation of the protein-
DNA complex during electrophoresis.  
1.3.4 EMSAs to investigate the effect of increase in the amount of protein and the effect of 
EDTA treatment. EMSA was performed using different concentrations of the in vitro wild type 
P. gingivalis OxyR in the binding reaction. The amount of protein in each binding reaction was 
increased keeping the amount of the labeled DNA used for binding, the same. 5 µl of the labeled 
DNA fragments PG0964 (Figure 8A) and hmu (Figure 8B) were used for each binding reaction 
(Refer to table 1 and the list of primers 1 for details). EMSAs were carried under condition B.  
 Lane 1 marks the position of unbound DNA on the gel. Lanes 2,3,5,6 contain binding 
reactions set with increasing concentrations of OxyR. For PG0964 it was evident that with 1 µg 
and 1.87 µg of protein a partial shift was observed. With 2.5 µg and 3.12 µg of protein smears 
were observed. For hmu, 1 µg and 1.87 µg of protein was not capable to decrease the mobility of 
the DNA fragment clearly. But smears were observed when protein concentration above 2.5 µg 
was used for binding indicating the formation of protein-DNA complex in these cases.  
 To check if the metal chelator EDTA has any effect on OxyR-DNA binding, protein was 
treated with 0.33M EDTA for half an hour before using it for binding with the DNA fragment. 
Lane 4 in figure 8A and 8B has the binding reaction carried out in the presence of EDTA-treated 
protein. Although the amount of protein in lane 4 is same as that in lane 3, lane 4 does not show 
the partial shift which was evident in lane 3. This indicated that the metal chelator EDTA might 
be responsible for abrogating the shift.  
  To further investigate the effect of EDTA on OxyR-DNA binding, EMSA was again 
carried out using 5 µl of labeled DNA fragments PG0964, hmu. Part 2 and 3 of the sod fragment  
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Figure 8. EMSA using different concentrations of in vitro 
transcribed wild type OxyR 
with DNA fragment PG0964 (A) and hmu (B), where Lane 1 –  
DNA only, Lane 2 - DNA+ 1 µg OxyR, Lane 3 - DNA+ 1.87 µg 
OxyR, Lane 4 - DNA+ 1.87 µg  OxyR treated with 0.33M EDTA, 
Lane 5 - DNA+ 2.5 µg OxyR, Lane 6- DNA+ 3.12 µg OxyR. 
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were also used. This time more protein was utilized for binding than used in Figure 8 and the 
concentration of EDTA used for treating the protein was lesser (Refer figure 9 for details). 
Protein was treated with EDTA for half an hour before setting the binding reaction. EMSAs were 
carried out under condition B. Un-treated 2.73 µg of OxyR binds to the DNA fragments used, 
evident by the smear in lane 2, indicating that there is a decrease in the mobility of the DNA 
fragment after incubating it with the untreated wild type OxyR. Lane 3 has the binding reaction 
in which treated OxyR was utilized. No smear or shift in the position of DNA is evident in this 
lane indicating that OxyR has not bound to the DNA fragment.  
1.3.5. EMSA using mutant proteins. 
1.3.5.I.. EMSA using crude lysates of the mutant proteins. Crude lysates were prepared for 
mutant OxyR proteins, C199S and H17A as mentioned in section 1.3.2.II.B. 5.5 µl of these 
lysates were used to set binding reactions with 5 µl of the labeled DNA fragments PG0964. 
PG0304, PG1307 (Figure 10). (Refer to list of primers for primer sequences.) Again, in these 
images the first lane marks the position of the unbound DNA fragment. The un-induced lysates 
serve as negative controls. DNA fragments did not show clear shift after incubation with induced 
lysates of the mutant proteins. 
 One drawback of the EMSAs shown in figure 10A was, accidentally, less than 1mM 
IPTG was used for protein expression while making the induced cell lysates. To prepare the 
mutant cell lysates exactly in the same manner as prepared for wild type lysates, fresh cell 
lysates were prepared for mutant C199S using 1mM IPTG for induction. EMSA was repeated 
using this new cell lysate (Figure 10B). Any shift in the position of DNA fragments was not 
evident with the new lysates of the mutant protein as well. All EMSAs using lysates were carried 
out under condition B.   
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Figure 9. EMSA for verification of effect of 
EDTA on binding of in vitro transcribed wild 
type OxyR using DNA fragment PG0964 
(A), hmu (B), sod-2 (C) and sod-3 (D), where 
Lane 1 – DNA only, Lane 2 - DNA+ 2.73 µg  
OxyR, Lane 3 - DNA+ 2.73 µg  OxyR 
treated with 0.13M EDTA. 
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1   2   3    4   5
PG0964 F,R
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PG0304 F, HR
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Figure 10.  EMSA using mutant OxyR cell lysates, where, A –  
IPTG < 1 mM and B – IPTG = 1 mM. Lane 1 – DNA only, Lane 
2 – DNA+ un-induced mutant C199S cell lysate, Lane 3 – DNA+ 
Induced mutant C199S cell lysate, Lane 4 – DNA+ un-induced 
mutant H17A cell lysate, Lane 5 – DNA+ Induced mutant H17A 
cell lysate.  
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1.3.5.II. EMSA using in vitro mutant proteins. As in vitro transcribed wild type P. gingivalis 
OxyR was able to bind with the DNA fragments used, we were interested in knowing whether 
the OxyR muatants C199S and H17A bind to those fragments or not. These mutant proteins were 
made as mentioned in section 1.3.2.II.C and as mentioned in the materials and methods section. 
EMSAs were carried out using 1.7 µg of each of these mutant proteins for binding with 5 µl of 
the labeled DNA fragments. 1.7 µg of in vitro transcribed wild type OxyR was used as a positive 
control. Fragments used were PG1307 (Figure 11A), hmu (Figure 11B) and PG0964 (Figure 
11C) (Refer table 1 and the list of primers 1 for details regarding DNA fragments). 
 Lane 1 marks the position of the unbound DNA. Lane 2 containing binding reaction with 
the wild type protein shows shift in the position of the DNA fragment indicating the formation of 
DNA-OxyR complex. Such a shift is not observed in lanes 3 and 4 suggesting that the mutant 
proteins are not binding with the DNA fragment. 
 1.3.6. Comparison between P. gingivalis OxyR and E. coli OxyR binding. 
1.3.6.I. Protein expression and purification. To compare the binding of P. gingivalis OxyR and 
E. coli OxyR to their predicted binding sites, we performed EMSAs with both of them. For that a 
fresh batch of proteins was prepared. Wild type P. gingivalis OxyR and wild type E. coli OxyR 
were expressed in E.coli BL21(DE3) cells and purified using Halo resin replicating the protocol 
used in section 1.3.2.II.A and in materials and methods section. A denaturing gel is run by 
loading 5 µg of the purified proteins under reducing and non-reducing conditions to check the 
purity of the sample (Figure 12). For P. gingivalis OxyR and for E. coli OxyR a prominent band 
at 37 KD was observed under reducing and non-reducing conditions.  
1.3.6.II. EMSAs using freshly purified E. coli OxyR and P. gingivalis OxyR. EMSAs were 
performed using freshly purified E. coli OxyR and P. gingivalis OxyR. The protein  
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Figure 11. EMSA using in vitro transcribed OxyR mutants with DNA 
fragments PG1307 (A), hmu (B) and PG0964 (C) where Lane 1- DNA 
only, Lane 2 - DNA+ Wt. OxyR, Lane 3- DNA+ mutant C199S, Lane 
4- DNA+ mutant H123A. 
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Figure 12. SDS-PAGE gel image of the 
purified P. gingivalis OxyR and E. coli  
OxyR from batch 2, where Lane 1 – P. 
gingivalis OxyR under non-reducing 
conditions, Lane 2 – E. coli OxyR under non-
reducing conditions, Lane 3 – P. gingivalis 
OxyR under reducing conditions, Lane 4 – E. 
coli OxyR under reducing conditions. 
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concentrations were immeasurably low. So 10.5 µl of each of the proteins were used to set each 
binding reaction without concentrating the proteins. 1.5 µl of the labeled DNA fragment was 
used to set each binding reaction. As the aim was to compare binding by E. coli OxyR and P. 
gingivalis OxyR, DNA fragments utilized for EMSAs were among the predicted binding sites for 
either P. gingivalis OxyR or E. coli OxyR. Fragments used were IS , PGahpc1, PGahpc2, hmu 
(Refer to section 1.3.1 and list of primers 1 for details on DNA fragments used) (Figure 13A). A 
3% agarose gel was used for running the binding reactions. Fragments used earlier with in vitro 
P. gingivalis OxyR were also used for example, PG0964 and PG0360 (Figure 13B). A 1% 
agarose gel was used to run the binding reactions (Refer table 1 and the list of primers 1 for 
details regarding the DNA fragments). The components added in the binding reaction for this 
EMSA were same as those mentioned for condition A in materials and methods section except 
the amount of glycerol added was increased to 5% and EDTA was excluded from the binding 
reaction. Running buffer and gel buffer were prepared as mentioned in the materials and methods 
section with 5% glycerol added in both of them. A higher amount of glycerol was used for these 
assays as glycerol enhances the stability of the protein-DNA complex(48). Assays mentioned in 
section 1.3.2.VI , indicated  the role of EDTA in abrogating binding, hence EDTA was excluded 
from the binding reaction.   
 IGS protein (4 µg treated with hemin and DTT) and IGS DNA fragments were used just 
as experimental positive controls. IGS protein when treated with hemin under reducing 
conditions, binds to its target DNA site, serving as positive control (Figure 13A, lanes 1, 2).  
Though not complete, IS fragment showed a clear shift when incubated with E. coli OxyR. There 
was no change in the mobility of IS fragment when incubated with P. gingivalis OxyR (Figure 
13A, lanes 3-5). PGahpc1 and PGahpc2 showed a partial shift on incubation with E. coli OxyR  
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Figure 13.  EMSA using fresh purified 
wild type P. gingivalis OxyR and E. coli 
OxyR with different DNA fragments. 
A. Lane 1 – IGS DNA only, Lane 2 – 
IGS DNA + IGS protein treated with 
hemin, Lane 3 – IS DNA only, Lane 4 – 
IS DNA + E. coli OxyR, Lane 5 – IS 
DNA + P. gingivalis OxyR, Lane 6 – 
PG ahpc1 DNA only, Lane 7 - PG ahpc1 
DNA + E. coli OxyR, Lane 8 - PG 
ahpc1 DNA + P. gingivalis OxyR, Lane 
9 –  PG ahpc2 DNA only, Lane 10 – PG 
ahpc2 DNA + E. coli OxyR, Lane 11 - 
PG ahpc2 DNA + P. gingivalis OxyR, 
Lane 12 – hmu DNA only, Lane 13 – 
hmu DNA + E. coli OxyR Lane 14 - 
hmu DNA + P. gingivalis OxyR  
B.  Lane 1 – PG0964 DNA only, Lane 2 
- PG0964 DNA + E. coli OxyR, Lane 3 - 
PG0964 DNA + P. gingivalis OxyR, 
Lane 4 – PG0360 DNA only + Lane 5 – 
PG0360 DNA + E. coli OxyR, Lane 6 - 
PG0360 DNA + P. gingivalis OxyR. 
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but not with P. gingivalis OxyR (Figure 13A, lanes 6-11).  EMSAs done using hmu fragment 
were not conclusive (Figure 13A, lanes 12-14). For DNA fragments PG0964 and PG0360, 
incubation with E. coli OxyR resulted in a complete shift in the position of the DNA fragment 
indicating that E. coli OxyR binds to those fragments. But no shift was observed when these 
fragments were incubated P. gingivalis OxyR indicating that purified P. gingivalis OxyR does 
not bind to those fragments. These results were consistent with those mentioned in section 1.3.3. , 
where EMSAs were performed using purified, P. gingivalis  OxyR. 
  For this EMSA, as the concentrations of both the proteins used were not same, it was not 
appropriate to conclude anything. There was a possibility that concentration of P. gingivalis 
OxyR was so low that there was no visible change in the mobility of the fragment incubated with 
the protein. One more EMSA was performed exactly in the same manner, where equal 
concentrations of the two proteins were used to set the binding reactions. Proteins were 
concentrated using Centrifugal filter units (Millipore). 3.12 µg of each of the proteins was used 
with 1.5 µl of the labeled DNA fragment in a binding reaction.   
 IGS protein was again used along with IGS fragment. Untreated IGS protein which does 
not bind to its target site, served as an experimental negative control. IGS protein treated with 
hemin under reducing conditions, served as experimental positive control (Figure 14A, lanes 1-3). 
When incubated with E. coli OxyR, IS DNA fragment shows some smear suggesting that there is 
decrease in the mobility of the fragment due to formation of a DNA-protein complex. But this is 
not very well clear from the gel picture (Figure 14A, lanes 4-6). Thickness of the DNA-band for 
PGahpc1 fragment decreased after incubation with E. coli OxyR as compared to that for only 
DNA and after incubation with P. gingivalis OxyR (Figure 14A, lanes 7-9). Binding reactions 
with fragments, PGahpc2 and hmu did not show a clear shift Figure 14A, lanes 10-15).  
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Figure 14. EMSA using equal concentrations 
of purified wild type P. gingivalis OxyR and 
E. coli OxyR with different DNA fragments.  
A. Lane 1 – IGS DNA only, Lane 2 – IGS 
DNA + IGS protein treated with hemin, Lane 
3 - IGS DNA + IGS untreated protein,  Lane 4 
– IS DNA only, Lane 5 – IS DNA + E. coli 
OxyR, Lane 6 – IS DNA + P. gingivalis 
OxyR, Lane 7 – PG ahpc1 DNA only, Lane 8 
- PG ahpc1 DNA + E. coli OxyR, Lane 9 - PG 
ahpc1 DNA + P. gingivalis OxyR, Lane 10 –  
PG ahpc2 DNA only, Lane 11 – PG ahpc2 
DNA + E. coli OxyR, Lane 12 - PG ahpc2 
DNA + P. gingivalis OxyR, Lane 13 – hmu 
DNA only, Lane 14 – hmu DNA + E. coli 
OxyR Lane 15 - hmu DNA + P. gingivalis 
OxyR (Refer tables .. and … for details 
regarding DNA fragments).  
B.  Lane 1 – PG0964 DNA only, Lane 2 - 
PG0964 DNA + E. coli OxyR, Lane 3 - 
PG0964 DNA + P. gingivalis OxyR, Lane 4 – 
PG0360 DNA only + Lane 5 – PG0360 DNA 
+ E. coli OxyR, Lane 6 - PG0360 DNA + P. 
gingivalis OxyR. 
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 Fragments PG0964 and PG0360 showed a faint smear after incubation with E. coli OxyR. 
The DNA band as observed in lane 1 and 4 of figure14B was lost. This suggests that the 
fragments might be binding with the protein which decreased their mobility drastically. That was 
why a clear band was not observed in these lanes. After incubation with P. gingivalis OxyR there 
was no change in the mobility of the fragments indicating that again purified P. gingivalis OxyR 
did not bind to the fragments (Figure 14B, lanes 1-6).   
   All of the EMSAs mentioned above showed that the in vivo expressed and purified P. 
gingivalis OxyR does not bind to the predicted target DNA fragments while E. coli OxyR 
produced and treated in the same manner bind to its own target fragment as well as to the target 
fragment of P. gingivalis OxyR. The crude lysate of wild type P. gingivalis OxyR and the in 
vitro wild type P. gingivalis OxyR bound to the predicted binding sites but the results were not 
reproducible.    
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1.4. Results of in vivo characterization. The aim of in vivo characterization was to visualize 
OxyR-DNA binding under a fluorescent microscope. 
1.4.1. Approach 1 The first step towards visualizing direct binding of OxyR to its target DNA 
sequences was to observe expression of OxyR under fluorescent microscope. Strain V3080 was 
used for this purpose. Strain V3080 consists of E. coli BL21(DE3) expression cells which 
express P. gingivalis OxyR with a Halo tag at its C-terminus, from an expression vector. (For 
details on the strain and vector refer to materials and methods section 1.2.1) A Halo Tag 
TMRDirect ligand (Promega) which consists of a red-fluorescent reporter group and a reactive 
linker that binds covalently to the Halo tag protein was used to check expression of OxyR under 
fluorescent microscope with the help of a live cell microscopy experiment as described in 
materials and methods section 1.2.12. For this experiment, ‘microfluidic flow plate for bacteria’ 
(ONIX- CeLLASIC) was utilized. (Principle and design of the microfluidic plate used for this 
experiment have been elucidated in materials and methods section 1.2.11.)  
 Figure 15 displays the images captured during the experiment. First two inlet wells 
contained only LB media allowing the cells to grow for the first two hours of the experiment. 
The cells started to express protein when the media from inlet 3 was introduced as it contained 
the inducer of protein expression, IPTG. Media from inlet 3 also contained the fluorescent ligand 
which bound covalently with the HaloTag protein expressed along with OxyR, emitting a red 
fluorescence confirming the protein expression. With time the number of cells increased which 
can be seen from DIC images (Figure 15A). The protein expression also increased over time as 
indicated by increase in fluorescence with time (Figure 15B). 
 The HaloTag TMRDirect ligand proved to be useful for visualizing the expression of P. 
gingivalis OxyR tagged with a HaloTag protein under fluorescent microscope but some of the  
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Figure 15A. DIC (Differential interference contrast) images of the live cell 
microscopy experiment to monitor OxyR expression in real time captured 
on Zeiss Cell Observer Spinning Disc Microscope after every 15 minutes, 
starting from 0 minute to 5 hours.  
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Figure 15 B. Overlay of DIC + fluorescence images from the live cell microscopy 
experiment to monitor OxyR expression in real time captured on Zeiss Cell 
Observer Spinning Disc Microscope after every 15 minutes, starting from 0 minute 
to 5 hours.  
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aspects observed during the experiment made the use of ligand unsuitable for the further 
investigation.  For example, it was observed that the inclusion bodies were catching the ligand 
earlier than the intracellular Halo-tagged OxyR suggesting that there can be a time-lag between 
expression of the protein and penetration of ligand in the cells. Another observation that all the 
cells in the given population were not uniformly emitting the red fluorescence suggested that the 
dye may not be penetrating all the cells uniformly. To avoid these pitfalls we decided to follow 
approach 2. 
1.4.2. Approach 2 Instead of using some external fluorescent agent like the ligand, expressing 
OxyR as a fusion protein fused with a fluorescent protein is definitely a better strategy. For this 
purpose, GFP (green fluorescent protein) and its various sophisticated analogues are the most 
commonly used fluorescent probes in molecular biology77. A major drawback of all the members 
of the GFP family is that they require molecular oxygen for the synthesis of their respective 
chromophores, making them unsuitable to use as fluorescent probes under strict anaerobic 
conditions78. As the ultimate goal of our step by step investigation is to observe OxyR-DNA 
binding in vivo in P. gingivalis which is an obligate anaerobic bacterium, GFP derivatives are of 
no use. This fact prompted the use of a flavin mononucleotide (FMN) based fluorescent protein 
(FbFP) for making a fusion protein with OxyR. The FMN-based protein pGLOW-Bs2 consists of 
the photoactive domain of the blue-light photoreceptor YtvA derived from B. subtilis in which 
Cys62 is mutagenized to Ala62 to increase the fluorescent intensity79. Thus, the aim of approach 
2 was to express OxyR as a fusion protein with pGLOW-Bs2 to monitor its expression and 
eventually binding. Two different strategies were used as described in materials and methods 
section 1.2.13 and 1.2.17 to design the construct that would express OxyR fused with pGLOW-
Bs2.   
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1.4.2.I Strategy 1 for approach 2. Strategy 1 involved replacement of the sequence encoding 
HaloTag from plasmid DNA V3080 with the sequence encoding pGLOW-Bs2. For this purpose, 
pGLOW-Bs2-Stop(pUC18) vector bought from the company was reconstructed as mentioned in 
section 1.2.13. Xhoi/EcoRi double digestion was carried out on the re-constructed pUC18 
construct and on the plasmid DNA V3080 (Refer section 1.2.14 for details). Figure 16 shows the 
digestion reactions ran on a 1% Agarose gel. V3080, when digested, showed two bands, one of 
about 1000 bp in size indicated digested HaloTag sequence and the other of about 4086 bp in 
size indicated the digested vector. The band indicating a digested vector (Figure 16, lane 1) was 
excised and extracted from the gel to use for ligation with the insert. On digestion, the re-
constructed pUC18 vector also showed two bands, the one having the size of about 3900 bp 
indicated the digested pUC18 vector and the one of size of about 400 bp indicated the digested 
pGLOW-Bs2 sequence (Figure 16, lane 2). This band of size 400 bp is the insert that needed to 
be cloned in digested V3080. This band was also excised and extratcted. A ligation reaction was 
set as described in section 1 2.15 using the gel extracted acceptor vector and insert. After colony 
screening, the plasmid DNAs isolated were sent for sequencing. The sequencing results (not 
included) indicated that the pGLOW-Bs2 was present downstream and in frame with the P. 
gingivalis OxyR present in construct V3080. Ideally this construct was expected to express the P. 
gingivalis OxyR as a fusion protein with the pGLOW-Bs2, resulting in emission of a cyan-green 
fluorescence after protein expression. To check the fluorescence, this construct was transformed 
in E. coli expression cells and the culture slide was prepared as mentioned in section 1.2.15 to 
observe it under the fluorescence microscope. 
 No cyan green fluorescence was observed (Images not included). The reason for this 
could be either the fusion protein was not expressed or the fluorescent protein Bs2 was not able  
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 Figure 16. Agarose gel showing 
plasmid DNA V3080 (Lane 1) 
and the re-constructed pUC18 
vector (Lane 2) digested with 
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to achieve a proper conformation after expression. For emitting fluorescence, conformation of 
the fluorescent protein is critical. Even though it is expressed as a fusion protein, care must be 
taken to allow the two proteins to fold independently. With this goal, strategy 2 was applied to 
make the fusion protein.           
1.4.2.II. Strategy 2 for approach 2. Studies showed that a truncated YtvA that consists of only 
photoreceptor domain, forms a stable homodimer in solution79. Hence it was decided to 
incorporate a ribosomal binding site (RBS) in between OxyR and the sequence encoding 
pGLOW-Bs2 which will be cloned in frame with the OxyR downstream of OxyR. This 
incorporation might help pGLOW-Bs2 to fold independently as a dimer and once properly 
folded pGLOW-Bs2 should emit cyan-green fluorescence. Keeping this concept in mind, three 
constructs were designed as mentioned in materials and methods section 1.2.17. 
 Three inserts which were to be cloned in these three constructs were amplified from 
pGLOW-Bs2-Stop(pUC18) using primer pairs FP1-RP (for two amplifications) and FP2-RP (for 
one amplification) as mentioned in section 1.2.18 and were run on 2% agarose gel to check the 
amplification (Figure 17A). All the three inserts should have a size of around 415 bp. An 
undesired band of 3kb was also observed in all the samples. Hence the band of desired size (450 
bp) was gel purified for all the three samples. The gel purified inserts were used to set digestion 
with restriction enzymes Xhoi/EcoRi. 
 Acceptor vectors V3107 and V3080 were digested with Xhoi/EcoRi and ran in a gel to 
excise the desired band. (Figure 17 B). A DNA piece encoding Halotag protein was cut due to 
digestion by enzymes Xhoi and EcoRi as indicated by a band of size 1000 bp on the gel, for each 
plasmid DNA. The bigger band indicates the digested acceptor vector piece. The bigger bands 
for each vector were excised and gel extracted. The gel extracted acceptor vectors were used to  
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Figure 17A. Agarose gel to check the amplification of 
pGLOW-Bs2 inserts, where Lane 1, 2 – Inserts amplified 
with primer pair FP1-RP, Lanes 3 – Insert amplified with 
primer pair FP2-RP.  
Figure 17B. Vectors V3080 (lane 1) and V3107 (lane 2) 
digested with Xhoi and EcoRi 
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set ligation reactions. Three ligation reactions were set to make constructs P, Q and R as 
mentioned in section 1.2.18 and section 1.2.15. 
   Plasmid DNAs isolated from many samples after colony screening, were sent for 
sequencing. Figure 18 A and B are examples of the sequencing results obtained. Sequencing 
results indicated that for all the three ligation reactions the desired constructs were not obtained. 
In most of the cases some totally different sequence had got inserted downstream the Xhoi 
recognition sequence as indicated in figure 18A and 18B. From the trend observed in the 
sequencing results it was concluded that some undesirable sequences were getting amplified as 
inserts. Hence, it was necessary to check the inserts by sequencing before cloning downstream 
OxyR present in vectors V3080 and V3107. To achieve this purpose, strategy 3 was applied.  
1.4.2.III. Strategy 3 for approach 2. The final aim of this strategy is to obtain constructs P,Q 
and R mentioned in strategy 2 but strategy 3 involves one additional step of cloning the 
amplified inserts into a PCR vector to check the amplified sequence, before cloning the inserts 
into Flexi vectors. For this purpose, PCR vector TOPO2.1 (Invitrogen) was used as mentioned in 
section 1.2.19. 
   After TOPO cloning and transformation colonies were screened and plasmid DNAs were 
sent for sequencing. Figure 19 A shows the sequence of the insert amplified with primer pair 
FP1-RP cloned into TOPO2.1 vector (Named as P1). This sequence indicated that a full length 
Bs2, along with its stop codon had got cloned into TOPO vector. All the new upstream-
downstream sequences that were inserted, for example, Xhoi recognition sequence, EcoRi site 
and E. coli RBS were present at the right place. Figure 19 B shows the sequence for the insert 
amplified with primer pair FP2-RP and cloned into TOPO vector (Named as P2). For this 
cloning also sequence was as expected, with Xhoi, EcoRi recognition sequences, P. gingivalis  
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NNNNNNNNNNCGNNNNTCGTGACNGTTGNNGGCTTGCTGCGTTCGGCCGTCCCATCGGATATGCACAAGTTGCAGACAGG
GCAGCATTTGGCTGTTTCTCTCGAGCCAACCACTGAGGATCTGTACTTTCAGAGCGATAACGATGGATCCGAAATCGGTACT
GGCTTTCCATTCGACCCCCATTATGTGGAAGTCCTGGGCGAGCGCATGCACTACGTCGATGTTGGTCCGCGCGATGGCACC
CCTGTGCTGTTCCTGCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCATGTTGCACCGACCCATCGCT
GCATTGCTCCAGACCTGATCGGTATGGGCAAATCCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCAT
GGATGCCTTCATCGAAGCCCTGGGTCTGGAAGAGGTCGTCCTGGTCATTCACGACTGGGGCTCCGCTCTGGGTTTCCACTG
GGCCAAGCGCAATCCAGAGCGCGTCAAAGGTATTGCATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCC
AGAATTTGCCCGCGAGACCTTCCAGGCCTTCCGCACCACCGACGTCGGCCGCAAGCTGATCATCGATCAGAACGT
A
NNNNNNNNNNNGCTATGAGCAGCTGGCAGAGGCCATCCGCGCAAGANTGGATGGCCATTTCGATAAAGTTTTAAAACAGG
CGGTTGTTTTGCNGGAGGGTAGCACTGAGGCTCTGCTGCCAGCGCTGGCTGTGCCGGATCAGCGCNNACGTANTGGGGTT
GNTTNCTGCCGTGCATTGTGCCGGAACCGCGCCANACTATGGGCCTGGTCGATGTTGGTCCGCGCGATGGCACCCCTGTGC
TGTTCCTGCACGGTAACCCGACCTCCTCCTACGTGTGGCGCAACATCATCCCGCATGTTGCACCGACCCATCGCTGCATTGC
TCCAGACCTGATCGGTATGGGCAAATCCGACAAACCAGACCTGGGTTATTTCTTCGACGACCACGTCCGCTTCATGGATGCC
TTCATCGAAGCCCTGGGTCTGGAAGAGGTCGTCCTGGTCATTCACGACTGGGGCTCCGCTCTGGGTTTCCACTGGGCCAAG
CGCAATCCAGAGCGCGTCAAAGGTATTGCATTTATGGAGTTCATCCGCCCTATCCCGACCTGGGACGAATGGCCAGAATTTG
CCCGCGAGACCTTCCAGGCCTTCCGCACCACCGACGTCGGCCGCAAGCTGATCATCGA………….  
B
Figure 18A. Sequencing result obtained after cloning pGLOW-Bs2 downstream P. 
gingivalis OxyR present in Flexi vector where blue, bold letters indicate the end part of 
the sequence of P. gingivalis OxyR 
Figure 18B. Sequencing result obtained after cloning pGLOW-Bs2 downstream E. coli 
OxyR present in Flexi vector where blue, bold letters indicate the end part of the 
sequence of E. coli OxyR 
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TOPO2.1…..AATTCGGCTTGAGCTCTCGAGTGAGGAGATATGGCGTCGTTCCAGTCGTTCGGCATCCCGGGCCAGCTGGAA
GTCATCAAGAAGGCGCTGGATCACGTGCGCGTCGGCGTGGTCATCACCGATCCCGCGCTGGAAGATAACCCGATCGTCTA
CGTGAACCAGGGCTTCGTGCAGATGACCGGCTACGAGACCGAGGAAATCCTGGGCAAGAACGCGCGCTTCCTCCAGGGG
AAGCACACCGATCCGGCGGAAGTGGACAACATCCGCACCGCGCTGCAAAATAAAGAACCGGTCACCGTGCAGATCCAGA
ACTACAAGAAGGACGGCACGATGTTCTGGAACGAACTGAACATCGATCCGATGGAAATCGAGGATAAGACGTATTTCGTC
GGCATCCAGAACGACATCACCAAGCAGAAGGAATATGAAAAGCTGCTTGAATGAGAATTCAGTCAGAAGCCGA 
…….TOPO 2.1
A
TOPO2.1…..NCGAGCTCGGATCCNCTAGTAACGGCCGCCAGTGTGCTGGAATTCGGCTTGAGCTCTCGAGAAATAAGAAACA
ATTATGGCGTCGTTCCAGTCGTTCGGCATCCCGGGCCAGCTGGAAGTCATCAAGAAGGCGCTGGATCACGTGCGCGTCGG
CGTGGTCATCACCGATCCCGCGCTGGAAGATAACCCGATCGTCTACGTGAACCAGGGCTTCGTGCAGATGACCGGCTACG
AGACCGAGGAAATCCTGGGCAAGAACGCGCGCTTCCTCCAGGGGAAGCACACCGATCCGGCGGAAGTGGACAACATCCG
CACCGCGCTGCAGAATAAAGAACCGGTCACCGTGCAGATCCAGAACTACAAGAAGGACGGCACGATGTTCTGGAACGAA
CTGAACATCGATCCGATGGAAATCGAGGATAAGACGTATTTCGTCGGCATCCAGAACGACATCACCAAGCAGAAGGAATA
TGAAAAGCTGCTTGAATGAGAATTCAGTCAGAAGCCGAATTCTGC…TOPO 2.1
B
 
Figure 19A. Sequence of vector P1 (Bs2 amplified with primer pair FP1-RP cloned in 
TOPO2.1 PCR vector),  where Green, bold, underlined letters - the sequence of Bs2, 
Pink, bold, underlined letters - recognition sequences of Xhoi, EcoRi, Dark pink, bold, 
underlined letters – sequence for E. coli RBS, Red, bold, underlined letters – stop codon, 
pink letters – primer sequences, Black letters- sequence from TOPO vector. 
Figure 19B.  Sequence of vector P2 (Bs2 amplified with primer pair FP2-RP cloned in 
TOPO2.1 PCR vector),  where Green, bold, underlined letters - the sequence of Bs2, 
Pink, bold, underlined letters - recognition sequences of Xhoi, EcoRi, Dark pink, bold, 
underlined letters – sequence for P. gingivalis RBS, Red, bold, underlined letters – stop 
codon, pink letters – primer sequences, Black letters- sequence from TOPO vector 
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RBS, full length Bs2 and stop codon all present at the expected location. Sequencing of the 
cloned TOPO vectors confirmed that the inserts to be cloned into flexi vectors were having the 
expected sequences. 
  Hence the next step was digestion of TOPO vectors P1, P2 and acceptor vectors V3107, 
V3080 with Xhoi and EcoRi.  After the incubation for digestion was over, all the digested 
vectors were run Agarose gel. Figure 20A shows the acceptor vectors V3080 and V3107 
digested with Xhoi, EcoRi in lanes 1 and 2 respectively, indicated HaloTag protein coding 
sequence which is digested out from the vector. The bigger bands in both the lanes indicated the 
digested acceptor vectors. 
These bands were gel extracted using Quiagen gel extraction kit and used for ligation. 
 Figure 20 B shows the digested constructs P1 and P2 run on a 2% Agarose gel. Both the 
constructs showed a band of size around 450 bp indicating insert which was digested out from 
the TOPO vector and a band of size 3.9 kb indicating digested TOPO vector. The bands for 
digested insert for both the constructs were excised from the gel and extracted. They were used 
for ligation.  
 Insert from P1 was ligated with digested vector V3107 to make construct P, and with 
digested vector V3080 to make construct Q. Insert from P2 was ligated with digested vector 
V3080 to make construct R. Ligation reactions were set as mentioned in step 4 of strategy 2.        
   For all the three ligation reactions plasmid DNAs were sent for sequencing after colony 
screening. Sequence for construct P was exactly as designed (Figure 21A). Hence construct P is 
ready to be transformed into EC BL21(DE3) expression cells to monitor expression of EC OxyR 
expressed as a fusion protein with pGLOW-Bs2 under fluorescent microscope. The construct can 
also be utilized to visualize EC OxyR-DNA binding as mentioned in future directions.  
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Figure 20A. Vectors V3080 (lane 1) and V3107 (lane 2) 
again digested with Xhoi and EcoRi. 
Figure 20B. Construct P1 (lane 1) and construct P2 (Lane 
2) digeted with Xhoi and EcoRi.  
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NTGAGCAGCTGGCAGAGGCCATCCGCGCAAGAATGGATGGCCATTTCGATAAAGTTTTAAAACAGGCG
GTTGTTTCTCTCGAGTGAGGAGATATGGCGTCGTTCCAGTCGTTCGGCATCCCGGGCCAGCTGGAAGTCA
TCAAGAAGGCGCTGGATCACGTGCGCGTCGGCGTGGTCATCACCGATCCCGCGCTGGAAGATAACCCGA
TCGTCTACGTGAACCAGGGCTTCGTGCAGATGACCGGCTACGAGACCGAGGAAATCCTGGGCAAGAACG
CGCGCTTCCTCCAGGGGAAGCACACCGATCCGGCGGAAGTGGACAACATCCGCACCGCGCTGCAAAATA
AAGAACCGGTCACCGTGCAGATCCAGAACTACAAGAAGGACGGCACGATGTTCTGGAACGAACTGAACAT
CGATCCGATGGAAATCGAGGATAAGACGTATTTCGTCGGCATCCAGAACGACATCACCAAGCAGAAGGAA
TATGAAAAGCTGCTTGAATGAGAATTCTAGAGTCGACCTGCAGGCATGCAAGCTGATCCGGCTGCTAACA
AAGCCCGAAAGGAAGCTGAGTTGGCTGCTGCCACCGCTGAGCAATAACTAGCATAACCNA 
A
GTGACNGTTGATTGGCTTGCTGCGTTCGGCCGTCCCATCGGATATGCACAAGTTGCAGACAGGGCAGCA
TTTGGCTGTTTCTCTCGAGTGAGGAGATATGGCGTCGTTCCAGTCGTTCGGCATCCCGGGCCAGCTGGAA
GTCATCAAGAAGGCGCTGGATCACGTGCGCGTCGGCGTGGTCATCACCGATCCCGCGCTGGAAGATAAC
CCGATCGTCTACGTGAACCAGGGCTTCGTGCAGATGACCGGCTACGAGACCGAGGAAATCCTGGGCAAG
AACGCGCGCTTCCTCCAGGGGAAGCACACCGATCCGGCGGAAGTGGACAACATCCGCACCGCGCTGCAA
AATAAAGAACCGGTCACCGTGCAGATCCAGAACTACAAGAAGGACGGCACGATGTTCTGGAACGAACTGA
ACATCGATCCGATGGAAATCGAGGATAAGACGTATTTCGTCGGCATCCAGAACGACATCACCAAGCAGAA
GGAATATGAAAAGCTGCTTGAATGAGAATTCGAGCTCGGTA
B
NNTTCGTGACNGTTGATTGGCTTGCTGCGTTCGGCCGTCCCATCGGATATGCACAAGTTGCAGACAGGG
CAGCATTTGGCTGTTTCTCTCGAGAAATAAGAAACAATTATGGCGTCGTTCCAGTCGTTCGGCATCCCGG
GCCAGCTGGAAGTCATCAAGAAGGCGCTGGATCACGTGCGCGTCGGCGTGGTCATCACCGATCCCGCGC
TGGAAGATAACCCGATCGTCTACGTGAACCAGGGCTTCGTGCAGATGACCGGCTACGAGACCGAGGAAAT
CCTGGGCAAGAACGCGCGCTTCCTCCAGGGGAAGCACACCGATCCGGCGGAAGTGGACAACATCCGCAC
CGCGCTGCAGAATAAAGAACCGGTCACCGTGCAGATCCAGAACTACAAGAAGGACGGCACGATGTTCTGG
AACGAACTGAACATCGATCCGATGGAAATCGAGGATAAGACGTATTTCGTCGGCATCCAGAACGACATCAC
CAAGCAGAAGGAATATGAAAAGCTGCTTGAATGAGAATTCAGTCAGAAGCC 
C
 
Figure 21A. Sequence of construct P where, where Blue, blue letters – Sequence from 
the end part of E. coli OxyR, Green, bold, letters - the sequence of Bs2, Pink, bold, 
underlined letters - recognition sequences of Xhoi, EcoRi, Dark pink, bold, underlined 
letters – sequence for E. colis RBS, Red, bold, underlined letters – stop codon, pink 
letters – primer sequences, Black letters- sequence from Flexi vector. 
Figure 21B. Sequence obtained while making construct Q where, where Blue, blue 
letters – Sequence from the end part of P. gingivalis OxyR, Green, bold, letters - the 
sequence of Bs2, Pink, bold, underlined letters - recognition sequences of Xhoi, EcoRi, 
Dark pink, bold, underlined letters – sequence for E. coli RBS, Red, bold, underlined 
letters – stop codon, pink letters – primer sequences. 
Figure 21C. Sequence obtained while making construct R where, Blue, blue letters – 
Sequence from the end part of P. gingivalis OxyR, Green, bold, letters - the sequence of 
Bs2, Pink, bold, underlined letters - recognition sequences of Xhoi, EcoRi, Dark pink, 
bold, underlined letters – sequence for P. gingivalis RBS, Red, bold, underlined letters – 
stop codon, pink letters – primer sequences. 
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 Sequences for constructs Q and R were not totally as expected as the sequence 
downstream of the inserted Bs2, was weird (Figure 21B, 21C). It was not matching with the 
sequence from the Flexi vector downstream of the EcoRi recognition sequence in Flexi vector. 
Although Bs2 was in frame with OxyR and every other aspect of the sequence is perfect, 
construction of Q and R is not complete due to the weird downstream sequences. Digestion and 
ligation needs to be repeated on these samples to get constructs Q and R.  
1.4.3. Making a positive control construct.  In all the earlier constructs made pGLOW-Bs2 was 
expressed as a fusion protein tagged at the C-terminus of OxyR. The expression and fluorescence 
from those constructs is dependent on expression of OxyR. An experimental positive control 
whose fluorescence is independent of OxyR-expression was needed. To prepare that pGLOW-
Bs2 alone needed to be expressed using pFC20K Halo Tag T7 SP6 Flexi Vector. Cloning and 
ligation was done as mentioned in section 1.2.20. 
Figure 22 shows the sequencing result. It indicates that the full length (411 bp) pGLOW-Bs2 
along with its stop codon is present downstream the T7 promoter in Flexi vector. According to 
the sequencing results obtained (Figure 22) pGLOW-Bs2-Stop downstream of the T7 promoter 
and hence should be expressed when IPTG was added. Hence it was expected to see a cyan-
green fluorescence spread over the entire area of the cells. Culture slide was prepared as 
mentioned in section 1.2.21. No true fluorescence was observed. The cyan-green fluorescence in 
the negative control culture was of same intensity. In fact for both the negative control culture 
and the positive control cultures the fluorescence intensity observed under all the fluorescent 
filters was the same. (Images not captured). These observations were consistent for all the three 
cultures induced with different concentrations of IPTG.  
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CCGACTCAGTGACTATAGATAAGGAGCGATCGCCATGGCGTCGTTCCAGTCGTTCGGCATC
CCGGGCCAGCTGGAAGTCATCAAGAAGGCGCTGGATCACGTGCGCGTCGGCGTGGTCATC
ACCGATCCCGCGCTGGAAGATAACCCGATCGTCTACGTGAACCAGGGCTTCGTGCAGATG
ACCGGCTACGAGACCGAGGAAATCCTGGGCAAGAACGCGCGCTTCCTCCAGGGGAAGCA
CACCGATCCGGCGGAAGTGGACAACATCCGCACCGCGCTGCAAAATAAAGAACCGGTCAC
CGTGCAGATCCAGAACTACAAGAAGGACGGCACGATGTTCTGGAACGAACTGAACATCGA
TCCGATGGAAATCGAGGATAAGACGTATTTCGTCGGCATCCAGAACGACATCACCAAGCA
GAAGGAATATGAAAAGCTGCTCGAGTGAGTTTCTCT  
 
 
Figure 22. Sequencing result of the positive control vector constructed using Flexi 
vector, where green letters – sequence encoding pGLOW-Bs2, red letters – stop codon, 
black letters – sequence from the Flexi vector. 
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1.4.4. Checking company’s expression vector for fluorescence. As the positive control 
expression vector made in the lab was not emitting any fluorescence, pGLOW-Bs2 cloned in an 
expression vector (pGLOW-KXN-Bs2) was bought from ‘evocatal’.  This expression vector was 
used to check if pGLOW-Bs2 expressed from this vector is emitting fluorescence. This vector 
was transformed in E. coli BL21(DE3) expression cells (Invitrogen). The procedure mentioned in 
section 1.2.21 was repeated for growing the culture and protein expression. A culture for strain 
V3080 was used as negative control. The slides were observed under the fluorescent microscope 
and fluorescence intensity was checked under all the fluorescent filters like CFP, DAPI, GFP, 
and DsRed. The camera settings were as mentioned in section 1.2.22. The images were captured 
for the slides prepared from the cultures induced with 1mM IPTG (Figure 23).   
 Again no intense fluorescence was observed for CFP.  In fact for both the negative 
control culture and the positive control cultures the fluorescence intensity observed under all the 
fluorescent filters was the same. These observations were consistent for all the three cultures 
induced with different concentrations of IPTG.  
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GFP
DsRed
DAPI
CFP
DIC
pGLOW-Bs2-KXN-Bs2 Control (-)
 
 
Figure 23. Images captured to check fluorescence 
after expression from construct pGLOW-Bs2-
KXN-Bs2 and from construct V3080 (negative 
control). 
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1.6. Discussion 
 
  In vitro characterization of binding started with CHIP-chip assay. This assay provided a 
list of target binding fragments for P. gingivalis OxyR (Refer table 1). These were different than 
those predicted in literature. The reason behind this discrepancy could be the difference in assay 
conditions. CHIP-chip assay was carried out in completely anaerobic conditions, whereas the 
fragments that are predicted binding sites for OxyR in literature are found under oxidative stress 
conditions62. Hence, while performing EMSAs, fragments provided by CHIP-chip assay, 
microarray studies as well as those mentioned in the literature are used. 
 At first, in vivo expressed and purified P. gingivalis OxyR was used for EMSAs. The 
very first purification process gave a protein of 50 kDa under denaturing, non-reducing 
conditions (Figure 2). The size of the full length OxyR is 35 kDa. Hence appearance of a band of 
50 kDa raised a question whether the protein is full length. There are two possibilities for 
appearance of this 50 kDa band. One possibility is that the purified, full length protein has 
formed an intra-molecular disulphide bond which is giving the protein a larger appearance. Other 
possibility is that the N-terminal domain has been cleaved by proteases and the dimer of the 
regulatory domain which has a size of about 25 kDa is responsible for the band of 50 kDa. This 
protein preparation did not bind with the tarhet DNA fragments during EMSAs. Absence of 
binding points towards the second possibility, indicating the absence of the N-terminal DNA 
binding domain in the purified preparation.  
 When a fresh batch of P. gingivalis OxyR was simultaneously expressed in vivo and 
purified along with E. coli OxyR both the proteins showed a band of about 37 kDa indicating 
that a full length protein is present in the purified preparation (Figure 12). During this 
purification process some more protease inhibitors were used than the first purification process. 
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This might be the reason behind purification of the full length protein.  But this full length P. 
gingivalis OxyR never bound to the target fragments whereas E. coli OxyR did bind. The 
binding of E. coli OxyR with the fragments which are the predicted binding sites for P. 
gingivalis OxyR is not surprising as both the proteins are the members of LysR family where the 
members display high conservation in the N-terminal DNA binding domain40,41. These EMSAs 
indicated that in vivo expressed and purified P. gingivalis OxyR may not be stable and hence 
was not able to bind with the DNA fragments in vitro. While the in vivo expressed and purified E. 
coli OxyR bound to its own target fragment as well as to the target fragment for P. gingivalis 
OxyR.   
 In vitro made and purified P. gingivalis OxyR also showed a band of 50 kDa after 
purification again indicating that N-terminal DNA binding domain has been cleaved and the 
band of 50 kDa is the dimer of the regulatory domain (Figure 3). There was one modification in 
the purification process when in vitro protein was purified. After addition of TEV protease, the 
elution was not applied to the His-link resin to remove TEV protease, instead 5 mM Zn2+ was 
added to inactivate the un-removed TEV-Protease. As application of the elution to His-link resin 
was skipped, it might resulted in retention of the cleaved N-terminal DNA binding domain in the 
purified preparation which showed a band at 15 kDa (Figure 3). May be the presence  of this 
cleaved DNA binding domain in the preparation resulted in binding of this preparation to the 
target fragments used (Figures 7, 8, 9). Presence of zinc ion in this preparation is also notable. As 
the mutant P. gingivalis OxyR proteins made in vitro were not able to bind with the same target 
fragments the residues mutated might have a crucial role in OxyR-DNA binding.  EDTA 
treatment was capable of abrogating the binding, zinc which was present in this preparation 
might had a role in binding. 
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 The HaloTag TMRDirect ligand was useful to monitor the expression of P. gingivalis 
OxyR but was not totally suitable for further investigation due to the pitfalls observed. Hence use 
of FMN-based fluorescent protein was theoretically ideal to make a fusion protein with OxyR. 
As we never got any fluorescence emission it is necessary first to check the expression and 
fluorescence of the pGLOW-Bs2 protein itself. Western blot can be used to check the expression. 
The expressed fluorescent protein can be run on a native gel to check if the band is fluorescent. 
Then various constructs can be made using that to make a fusion protein that will be fluorescent.       
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Appendix I 
 
 List of primers 1. 
  
1. PG0964F – 5’- GGTCATTTTATCGCAGCCTA -3’         
    PG0964R – 5’ -GAGCGGAGCATGATTTTAGC 
    Fragment size – 1038 bp 
 
2. PG 0360F- 5’-ATCGCCGGTCAGCATAGAGT-3’        
    PG0360R – 5’-ATCATTCGCAAGAGCGAAAA-3’ 
    Fragment size - 918bp 
 
3. PG1307F – 5’-AAAGGCTGTCCGCACTCAT-3’      
    PG1307R – 5’-GGTGAACATCTTTACTTCTGTCGTT-3’  
    Fragment size - 993bp 
 
4. PG0304F – 5’- AACAAGGACAAAGGCGGTGT -3’     
    PG0304HR – 5’- CATGGTCGCTCGTCAGATAA-3’ 
    Fragment size - 830bp 
 
5. PG1240F – 5’- TCGATGTAGCACGTCAGCTC-3’      
    PG1240R – 5’- CACTTTCACTTCCAATCTCTTCTTC-3’ 
    Fragment size - 636bp 
 
6. PG1240IFF – 5’- CGATATGTATGTCCGCGAAG-3’     
    PG1240IFR – 5’- GATGAGCTGTCCCCTTTCAA-3’ 
    Fragment size - 947bp 
 
7. PG1862IFF- TGATTATCCCATAAAGGGTGAGA-3’    
    PG1862IFR- ACCATTCTCGGAGCCTTGTA-3’ 
    Fragment size - 601bp 
 
8. hmuF - 5’-GCACCTGTTTATTGAGCAAAG-3’    
    hmuR – 5’-TCCCAGTTCAAATCGTTCTT-3’ 
    Fragment size - 500bp 
 
9. rbr F – 5’- GAGGTCGACTCTTTGTGTTCC-3’    
    rbrR – 5’- TGAGGTGGACTCTTTGTGTTC-3’ 
    Fragment size - 200bp 
 
10. sod1F – 5’- TGAACAATAAGACGAACTCCTTGTTTT-3’ 
      sod1R -5’- GCTTCATAATTCGGCTCTTGA-3’       
      Fragment size - 1000bp 
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11.  sod2F – 5’-AAGACGAACTCCTTGTTTTGAGAA-3’      
       sod2R – 5’-GCTTCATAATTCGGCTCTTGA-3’       
       Fragment size - 1000bp 
 
12. sod3F – 5’-TCAACGAAATGGTCTTGCTG-3’      
      sod3R – 5’- GCTTCATAATTCGGCTCTTGA-3’       
      Fragment size – 1000bp  
 
13. PGahpc1 F- 5’-CAGTCGATTGACAATGAAATCTCC-3’    
      PGahpc1 R- 5’-GTATGAACGTTTGTTTCAGGTG-3’ 
      Fragment size - 140 bp 
 
14. FP pg upstream ahpc – 5’ - CTGTCAAAGCATATGTTCAGATG - 3’    
      RP pg upstream ahpc - GAACGTTTGTTTCAGGTGC  
      Fragment size - 550bp 
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